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Despite being highly treatable with early intervention and preventative screenings, the 
overall mortality rate of colorectal cancer is substantially higher in participants with a 
preexisting mental disorder. Variables affecting the likelihood of completing screening 
for those with mental illnesses were unknown in people who obtain services from a 
Community Mental Health agency. Using the Health Belief Model, the proposed study 
investigated the effects of access to transportation, referral to screening, physical ability 
to complete the colonoscopy prep, type of procedure, awareness of the purpose of 
screening, anxiety, embarrassment, gender, race, and age to determine which affect 
completion of colorectal cancer screening. Significant relationships existed between 
embarrassment, fear of pain, fear of cancer, anxiety, physical ability to do testing, 
awareness of screening at age 50, FOBT vs Scope procedures, age of first screening, 
being told to get screening, knowing someone who had screening, and completion of 
colorectal cancer screening. In the binary logistic model Anxiety was negatively 
correlated and being told to get screening was positively correlated to completion of 
colorectal cancer screening and those choosing Scope were more likely to complete than 
those choosing FOBT.  The results of this study may effect positive social change by 
providing healthcare providers with an increased understanding of variables that 
influence colorectal cancer screening completion among persons with a diagnosed mental 
illness, resulting in a changing agenda for effective mental and physical health care in 
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Chapter 1: Introduction to the Study  
Introduction 
 Colorectal cancer is the third most common type of cancer, with an estimated 
93,090 new cases of colon cancer and 39,610 new cases of rectal cancer diagnosed in the 
United States in 2015 (American Cancer Society, 2015). Colorectal cancer is the second 
leading cause of cancer death behind lung cancer  (Centers for Disease Control, 2011) 
About 1 in 20 people  have a lifetime risk of being diagnosed with colorectal cancer, 
causing an estimated 49,700 deaths in 2015 (American Cancer Society, 2015). However, 
due to screening and early detection, the rate of death from colorectal cancer  has been 
dropping steadily for both men and women over the past 20 years (American Cancer 
Society, 2015). Despite this high incidence, the American Cancer Society (2011) 
estimated that only 52.3% of adults over the age of 50 have been screened for colorectal 
cancer. The Centers for Disease Control (2011) indicated that 1 in 3 adults between the 
ages of 50 and 75 were not up-to-date with recommended colorectal cancer screening. 
The US Preventive Services Task Force (2016) indicates that the  median age at death 
from colorectal cancer is 68 years. 
 One population that does not  demonstrate similar success in reduced mortality 
rates from cancer are those with mental illness. According to the U.S. Department of 
Health’s (2013) National Survey on Drug Use and Health, 18.6% of all adults in the 
United States are diagnosed with mental illness under the following qualifications: 
a) diagnosed with a mental, behavioral, or emotional disorder (excluding 
developmental and substance use disorders);  
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b) diagnosable currently or within the past year; and  
c) of sufficient duration to meet DSM-IV diagnostic criteria.  
An estimated 43.7 million adults in the United States have a diagnosed mental illness 
(U.S. Department of Health, 2013). In Michigan’s Community Mental Health (CMH) 
Services Programs, 78.95% of the 198,695 individuals with mental illnesses who 
received care lived in private residences, whereas 7.48% lived in institutions or 
supervised living situations, 4.38% are homeless, 1.33% lived with foster families, 1.32% 
were incarcerated, and 7.14% had unreported living situations (Michigan Department of 
Community Health, 2013). Regarding preventive care, Xiong, Bermudes, Torres, and 
Hales (2008) determined that in a sample of 229 outpatients with mental illnesses, more 
than 50% over the age of 50 had never received colorectal cancer screening, and 12% had 
completed a fecal occult blood stool test (FOBT) in the past year or a flexible 
sigmoidoscopy or colonoscopy in the past five years. Besides Xiong et al.’s (2008) study, 
however, research on colorectal cancer screening rates among those with mental illnesses 
is limited.  
 The limited extant research suggests a disparity in medical care for those with 
mental illnesses. Lawrence et al. (2013), Musuuza et al. (2013), and Viron and Stern 
(2010) determined that those with mental illness experienced different medical care than 
other patients. According to Happell, Brenda et al (2012), people with mental illness were 
20-30% less likely to receive breast, cervical and colorectal cancer screening than those 
without a mental illness.  
Baillargeon et al. (2011) examined 80,670 people over 65 years of age, for a 
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period of 12 years, and determined that those with mental disorders were more likely to 
be diagnosed with colon cancer only at autopsy, and with an unknown stage of cancer. 
This population is also more likely to have not received any treatment for colon cancer at 
death, thereby increasing colon cancer specific mortality (Baillargeon et al., 2011). 
Because screening drastically reduces mortality rates for patients with colorectal cancer, 
this study was designed to identify variables that predict colorectal cancer screening 
completion among those with mental illnesses. This chapter will provide background on 
the issue, statement of the study problem and purpose, research questions and hypotheses, 
and the parameters and significance of the study.  
Background 
At the time of this dissertation study, the U.S. healthcare system was very 
fragmented, resulting in unmet treatment needs and increased poor health among patients 
with mental disorders (Croft & Parish, 2012). Though colorectal cancer can be prevented 
through screenings (Canadian Task Force on Preventive Health Care, 2001), the 
complexity of the screening itself can be overwhelming for the average person and even 
more so for people with a serious and persistent mental illness (Viron & Stern, 2010; 
Musuuza et al., 2013).There is a significant body of literature about disparities in medical 
well-being and loss of lifespan stemming from persons having a serious and persistent 
mental illness (Lawrence, et al., 2013; Musuuza, et al., 2013; Viron & Stern, 2010). 
Previous research, exemplifiedthroughout this paper,  has highlighted the need for mental 
health and medical providers to pay attention to the medical needs of people with chronic 
and persistent mental illness.  
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Several solutions have been proposed for the problems of fragmented healthcare 
and its impact on those with mental illness. Some of these include recommendations for 
more involvement from Psychiatric Nurses (Scott & Happell, 2011) and adopting 
integrated health care systems that combine medical care within CMH agencies (Colton 
& Manderscheid, 2006). Other suggestions include putting a medical provider in the 
same building as mental health services or using Case Managers (who are usually 
Bachelor-prepared human services workers) to help coordinate medical care. Peer 
Advocates, who are former or current patients at the CMH agency, have also been used to 
assist individuals with obtaining and complying with recommended medical care. This 
help is needed due to cognitive impairments that often accompany a serious mental 
illness (Lawrence & Kisely, 2010). Although previous research has examined solutions to 
the problem, at the time of this dissertation study, no studies had identified predictive 
variables for colorectal cancer screening among the mentally ill who get services from a 
CMH.  
There are various types of screenings that include a fecal occult blood test 
(FOBT/FIT) that usually requires the individual to give three different samples of feces to 
the medical provider. Sometimes kits are provided so that the person can put a sample on 
a slide three different times and then mail it in to a laboratory.  According to the 
American College of Gastroenterology (2008) the following recommendations are:  
Colonoscopy every 10 years is the preferred colorectal cancer prevention test 




African Americans should begin colorectal screening with colonoscopy at age 45.  
More extensive guidelines explain when follow up screening is needed depending upon 
results and recognition of needs of different population groups. The United States 
Preventive Services Task Force (USPSTF; 2008) does not specify which test is preferred 
and provides evidence based pros and cons of screening methods. If the FOBT/FIT shows 
blood, a scope is recommended. It is recommended that the FOBT be done every year 
from age 50-75 for a person at average risk. A flexible sigmoidoscopy, a procedure in 
which a tube is inserted into the rectum to check for cancer up to the level of the colon, is 
recommended every five years, with the FOBT/FIT being done every three years. A 
colonoscopy looks at the entire colon and it is recommended that this be done every 10 
years. These guidelines are routinely updated as more research evolves.  
There are other tests such as a Barium Enema or swallowing a camera pill 
however, these test and others will not be addressed in this study. The questionnaire was 
designed to assess whether or not a FOBT/FIT or a scope procedure was done as patients 
may not be able to tell the name of the procedure (sigmoidoscopy or colonoscopy) but the 
preparation is difficult and the same for both of the scope procedures. The recommended 
number of times a person had these procedures done will also be investigated. For 
example, if someone had a FOBT/FIT once at age 50 and reaches age 65 without any 
other screening procedures, this indicates a lack of appropriate screening. Note that the 
FOBT may be confused with the FIT which is a different type of study of the fecal 
samples however, the term FOBT was used as participants may not know the difference 
between the types of samples tests done.  
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This study examined potential barriers to colorectal cancer screening, in hopes 
that identified barriers to colorectal cancer screening for those with mental illness, might 
apply to other preventive screenings. Once barriers to preventive healthcare are 
identified, this information can be used as part of a comprehensive Health Integration 
Model of care at a CMH agency or at a primary medical provider’s practice. Overall, the 
goal of this research was to determine which variables help to predict whether or not 
people with mental illness, who obtained care from a CMH agency, will complete 
colorectal cancer screening. 
Problem Statement 
  It has been estimated that 46.4% of Americans will experience mental illness 
and those with chronic mental illness will live 15-20 fewer years than people without 
mental illness (Kessler et al., 2005; Wahlbeck, Westmann, Nordentoft, & Gissler, 2011). 
Approximately 80% of these deaths are due to medical conditions, as opposed to suicide 
(Lawrence, Hancock, & Kisley, 2013). In addition to a shorter life span, the incidence of 
cancer in people with mental illness is 2.5 times greater than that of the general public 
and, in men younger than 50 years, 6.6 times the risk than that of the general public 
(Pandiani, Boyd, Bank, & Johnson, 2006, p. 1). Individuals with mental illness, who died 
of cancer, passed away at an average of 10 years earlier than individuals without mental 
illness (Musuuzo et al., 2013) 
The overall mortality rate (hazard ratio [HR]=1.33, 95% CI=1.31-1.36) and colon 
cancer-specific mortality rate (HR=1.23, 95% CI=1.19-1.27) is substantially higher in 
participants with a preexisting mental disorder (Baillargeon et al., 2011). Colorectal 
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cancer is highly treatable so long as screening measures and early intervention is 
available, supporting Viron and Stern’s (2010) assertion that people with mental illness 
are losing years of life to preventable, treatable diseases. At the time of this study, no 
prior research had determined variables that predict colorectal cancer screening among 
mentally ill populations.  
Purpose of the Study 
 The purpose of the proposed quantitative correlational survey design study was to 
identify variables that affect the probability of completion of colorectal cancer screening, 
whether through FOBT (stool sample), or sigmoid/colonoscopy (scope) by mentally ill 
subjects who obtain mental health care from a CMH agency. The data analysis  includes 
correlation analyses of the variables and logistic regression. The dependent variable is 
dichotomous, for example: Was colorectal cancer screening completed? The independent 
variables may be any level of measurement. The independent variables considered were 
age, type of mental illness, race, access to transportation, being told to get colorectal 
cancer screening, understanding the colonoscopy preparation, understanding why 
colorectal cancer screening is needed, fear of pain, and embarrassment. 
Research Questions and Hypotheses 
Research Question 1: What is the relationship between embarrassment, fear of 
pain, fear of cancer, anxiety and completion of colorectal cancer screening? 
• H01: There is no relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
• HA1: There is a relationship between embarrassment, fear of pain, fear of cancer, 
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anxiety and completion of colorectal cancer screening. 
Research Question 2: What is the relationship between transportation, physical 
ability to do testing, understanding the preparation for testing and completion of 
colorectal cancer screening? 
• H02: There is no relationship between transportation, physical ability to do 
testing, understanding the preparation for testing and completion of colorectal 
cancer screening? 
• HA2: There is a relationship between transportation, physical ability to do testing, 
understanding the preparation for testing and completion of colorectal cancer 
screening? 
Research Question 3: What is the relationship between demographics (education, 
age, gender, race) and completion of colorectal cancer screening? 
• H03: There is no relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
• HA3:  There is a relationship between demographics (education, age, gender, race) 
and completion of colorectal cancer screening? 
Research Question 4: What is the relationship between being physically able to 
complete the colonoscopy scope prep and completion of the test? 
• H04: There is no relationship between being physically able to complete the 
colonoscopy scope prep and completing the test.  
• HA4: There is a relationship between being physically able to complete the 
colonoscopy  scope prep and completing the test.  
9 
 
Research Question 5: What is the relationship between FOBT vs Scope 
procedures, age of first screening, and a diagnosis of colorectal cancer? 
• H05: There is no relationship between FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
• HA5: There is a relationship between, FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
Research Question 6: What is the relationship between who recommended 
colorectal cancer screening, being told to get screened, symptoms of cancer, knowing 
someone who had colorectal cancer, and completion of colorectal cancer screening? 
• H06: There is no relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer and completion of colorectal cancer screening. 
• HA6: There is a relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer and completion of colorectal cancer screening 
Theoretical Framework 
The health belief model (HBM) was the theoretical framework for the study. 
Hochbaum, Rosenstock, and Kegels (1950) formulated the HBM in 1950 to explain 
health behavior. During the 1950s, when tuberculosis (TB) was a public health threat and 
free testing became available, four constructs of the model emerged, involving a person’s 
perceptions of susceptibility, severity, barriers, and benefits. Glanz, Lewis, and Remer 
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(1997) extended the concepts of perceived susceptibility, severity, and barriers, stating 
that: 
• perceived susceptibility involves perceptions of risk for a disease;  
• perceived severity is the extent of understanding of the seriousness and 
consequences of a disease; and  
• perceived barriers include the person’s reasons for not receiving colorectal cancer 
screening.  
Hochbaum et al. (1950) indicated that the construct of perceived benefits is the value that 
a person places on changing health behaviors to reduce risks of getting colorectal cancer.  
The HBM states that the belief in a personal threat, together with the belief in the 
effectiveness of the proposed behavior, predicts the likelihood of patients’ behaviors 
(Rosenstock et al., 1988). This framework was designed to predict human behavior where 
preventive health is concerned. The hypothesis correlates with the survey questions and 
the constructs of this framework Questions are also included that assess clients who had 
or have colorectal cancer and variables related to getting a diagnosis, such as “Was the 
screening that caught the cancer, done later than the recommended age 50?” and “Was 
the cancer diagnosed due to symptoms prompting screening?” By applying this 
framework to colorectal cancer screening, I sought to identify predictive variables that 
increase colorectal cancer screening completion.  
Nature of the Study 
 This quantitative study was designed to identify which variables affect colorectal 
cancer screening completion. A convenience sample of CMH clients was gathered in 
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order to respond to a questionnaire; I only recruited participants who had insurance, so as 
to avoid variables affecting the uninsured. The state where this research took place 
incorporated expanded Medicaid over 6 months ago; therefore, most of the clients had 
Medicaid for at least six months, which again avoids outliers from the uninsured. Power 
analysis determined the sample size. People ages 50-75 were included in the survey, in 
alignment with the United States Preventive Services Task Force’s (2008) 
recommendation for colorectal cancer screening for people age 50-75 years or sooner, 
depending upon family history. Permission to survey clients at two different offices from 
the same agency was obtained, and a private place was used for completion of the survey. 
The researcher completed certification for human subject research through the Health 
Resources and Services Administration (HRSA, 2016).  Strict adherence to Walden 
University’s Research Ethics and Institutional Review Board (Walden, 2010) took place.  
The purpose of this quantitative study was to identify variables that affect the 
probability of completion of colorectal cancer screening by mentally ill subjects who 
obtain mental health care from a CMH agency. The data analysis included correlation 
analyses of the variables and logistic regression. The dependent variable wass 
dichotomous and.the independent variables were age, race, access to transportation, being 
told to get colorectal cancer screening, understanding the colonoscopy preparation, 
understanding why colorectal cancer screening is needed, and embarrassment.  
This quantitative study was comprised of several analyses. The correlation 
analysis d included correlations of all variables, with statistical significance reported, and 
included partial and semipartial correlations. The logistic regression  produced a 
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predictive model that shows how the independent variables affect the probability of the 
dependent variable outcome, which was whether colorectal cancer screening  completed. 
Interactions can be tested for, in the regression, by the coding of the variables. The 
logistic regression analysis produced a best fitting model with the most relevant and 
statistically significant predictors.  
Definitions  
Colonoscopy: An outpatient procedure in which the inside of the large intestine 
(colon and rectum) is examined by inserting a camera into the intestine in order to look 
for causes of problems (blood in the feces or abnormal bowel movements) or to check for 
potential problems such as polyps (a growth of tissue which could turn to cancer) or 
cancer itself. During the procedure, polyps are removed and checked for cancer. A person 
preparing for a colonoscopy has to drink clear liquids for a day, not eat any food, and 
take medication that causes diarrhea in order to empty the bowel (Cleveland Clinic, 
2010). This study did not differentiate between a sigmoidoscopy and colonoscopy 
because most patients do not know  the difference. 
Community Mental Health Department (CMH): In order to obtain services from a 
CMH a person must be a resident of a designated county, diagnosed with a primary 
mental illness that is severe and persistent, with or without a substance abuse problem 
that causes functional impairment (Detroit Central City, 2015). Some CMHs take in 
people that have a mental illness that may not be considered severe while others service 
people with developmental disabilities with or without a mental illness. Referrals are 
often made after a psychiatric hospitalization, discharge from prison, by family members, 
13 
 
courts, and medical providers. Services may include diagnosis and treatment of the 
mental/substance abuse illness through medication and therapy as well as assistance with 
obtaining insurance, disability, jobs, housing, food, medication compliance, and activities 
of daily living.  
Fecal Occult Blood Test/Fecal Immunoassay Test: A test that requires that a 
person provide three different fecal samples by putting them on a slide and mailing them 
or returning them to the prescriber. A kit is provided with directions and equipment 
needed. These tests look for blood which may be indicative of colorectal cancer 
(https://labtestsonline.org/understanding/analytes/fecal-occult-blood/tab/test). 
Dependent Variable 
 Completed colorectal cancer screening. A dichotomous variable (yes/no) 
corresponding to having completed colorectal cancer screening by colonoscopy. 
Independent Variables 
 Access to transportation: A dichotomous variable (yes/no) corresponding to 
individual’s ability to have someone willing to drive them to the facility, stay with the 
person during the cancer screen, and take them home. 
 Being told to get colorectal cancer screening: A dichotomous variable (yes/no) 
corresponding to individual being advised to receive CRC screening.  
 Being physically able to do the preparation: A dichotomous variable (yes/no) 
corresponding to individual’s ability to complete the prep which in involves clear liquids 
and diarrhea.  
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 Understanding why colorectal cancer screening is needed: A dichotomous 
variable (yes/no) corresponding to individual understanding why the colorectal cancer 
screening is necessary.  
 Embarrassment/Anxiety/Fear: A dichotomous variable (yes/no) corresponding to 
individual experiencing feelings of embarrassment over the colonoscopy procedure.  
 Race: A categorical (nominal) variable corresponding to an individual’s ethnicity 
or race was measured in the demographic portion of the survey. 
 Age: A continuous variable corresponding to an individual’s age was measured in 
the demographic portion of the survey. The age range is 50-75 years. 
Assumptions 
In order to conduct this study, some assumptions were required. Some of the 
routine assumptions regarding participants were that they will answer, to the best of their 
knowledge, the questions on the questionnaire, and that participation is voluntary. This 
assumption was required in order to enable a reliance on the data; furthermore, 
anonymity improves the likelihood that participants will participate as honestly as they 
are able (Ong & Weiss, 2000). Participants names or other identifying data was not 
collected. 
In addition, it was assumed that the sample size was sufficient to represent the 
population under study. To assess the minimum required size, Tabachnick and Fidell 
(2012) used a formula to determine that sampling 114 participants was needed in order to 
justify empirical validity. I also assumed that the participants understood the questions 
being asked because of the clearly worded description and photographs explaining what a 
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colonoscopy is. To assist this assumption, the wording developed for the questionnaire 
was elementary grade-level (i.e., “poop” was put in parentheses after the medical term 
“feces” in case someone was not aware what feces meant). Thus, it can be assumed that 
those participating in the study understood the questionnaire. A pilot study using experts 
in the field of psychiatry  validated the procedures and instruments used, assisting with 
the assumption that the final results would be valid.  
Scope and Delimitations 
Some gastrointestinal organizations recommend colorectal cancer screening at age 
45 for people of African descent; however, to keep the research simplified, the U.S. 
Preventive Services Task Force (2008) recommendations were followed which is age 50-
75 years. It is of note that if there is a family history of colorectal cancer, screenings 
might take place sooner, yet this recommendation will not be investigated in this study to 
simplify the research which is focusing on barriers to colorectal cancer completion 
among mentally ill populations. The sample will be from 114 or more individuals ages 50 
and over, who receive treatment at an east- and at a west-side CMH office in Detroit, 
Michigan. In the population under study, the majority of people in this sample were 
evenly distributed into male and female groups, were living with relatives or someone 
else in a private household, had a total household income of less than 10,000 dollars, 
were unemployed, and had Medicaid and/or Medicare (MDCH, 2013).  
Due to the lack of information about comorbidity and the multiple conditions that 
may be implicated, comorbidity was not considered in the proposed study. In addition, 
some patients with mental illnesses may have a lack of awareness about their present 
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medical conditions (Lawrence et al., 2013; Musuuza et al., 2013; Viron & Stern, 2010). 
Therefore, the anonymous survey design was chosen to elicit honest, open responses also 
precluding the inclusion of reliable data related to comorbid conditions in this population.  
The ability to understand sigmoidoscopy versus colonoscopy and fecal occult 
blood test versus fecal immunochemical testing, was not specified because such would be 
too complex to determine. Therefore, the colonoscopy prep was  explained and the 
individual was asked whether or not he or she would be able to complete such a 
procedure. It might be that some people have difficulty walking, which might result in the 
inability to get to the toilet with drug induced diarrhea. Or, withholding food in someone 
with diabetes might be a problem resulting in low blood sugar. The proposed study did 
not examine specific reasons, but rather a broader assessment of whether people think 
they could physically complete the preparation. These specific factors should be 
addressed in detail by a health provider when recommending colorectal cancer screening. 
This study focused on  the colonoscopy exam. Some gastrointestinal 
organizations recommend one of two types Fecal Occult Blood Test (FOBT), a guaiac 
blood detection test or a fecal immunochemical test (FIT), both of which involve putting 
a sample of feces from a few bowel movements onto a slide and sending them to a 
laboratory (Centers for Disease Control and Prevention, 2009). However, these tests do 
not check for the polyps that can turn to cancer. In a study by Quentero et al. (2012) a 
comparison was made of FIT and colonoscopy completion and it found that FITs were 
more likely to be completed than a colonoscopy and detection of cancer was comparable; 
therefore, some researchers suggested that using a less complicated screening procedure, 
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like the FIT, could increase screening compliance; However, late stage adenomas 
(cancer) were found more in the colonoscopy group (Quentero et al., 2012). For 
simplicity, only the colonoscopy (which could be a sigmoidoscopy) and the FOBT 
(which could be the FIT) was assessed. It is not likely that a patient would understand or 
know the difference between the two tests or which one was ordered when the 
preparation is the same. 
For this study, the Health Belief Model was used to interpret results. Several other 
theories have been applicable to this study, for example the Theoretical Stages of Change 
Model. However, that would focus on what stage the person was in, in regard to 
participation in CRC screening. For example, would the person be in the pre-
contemplation phase where he or she knows about the importance of CRC screening but 
wasn’t ready to think about it, or, the action stage where the person was ready to get the 
testing done. One of the reasons that this model wasn’t chosen is that it evaluates the 
knowledge that a person has (the importance of CRC screening) and what stage the 
person is in where completion of CRC occurs.  
In order to determine variables that affect CRC screening, the importance of the 
need for CRC screening needs to be evaluated as opposed to assuming everyone sampled 
is aware of this information. This is where the HBM is utilized.  
Limitations 
One limitation of the present study was that patients were not asked to identify 
their specific mental health diagnosis. Most people do not know their correct diagnosis 
due to different diagnoses and changing conceptions of disorders; therefore, that factor 
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was not asked of participants (Aboraya, Rankin, France, El-Missionary, & John, 2006). 
Even if a patient had an initial visit with a psychiatrist, the person is usually given a 
tentative diagnosis depending upon how good of a historian the person was, his or her 
age, substance use, and other factors which may change over time. For that reason, the 
general category of mental illness was used to avoid relying on self-reporting of the 
diagnosis.  
The questionnaire, study materials, and expected independent variables resulted 
from the use of the HBM as a theoretical framework. The use of this theory might have 
resulted in some bias in the data skewing towards support of the HBM. Logistic 
regressions were limited by the researchers’ ability to identify independent variables not 
explained by the HBM, including race and age (Bewick, Check, & Bal, 2005). 
Another limitation of this study might be the use of a convenience sample at two 
locations. Both locations are in an inner city, crime and poverty stricken area as opposed 
to a CMH Department located in a low crime or higher income area. Due to the 
convenience sampling procedure, geographical restrictions may exist which may restrict 
the generalizability of the results. Moreover, factors such as low income or crime rates 
were highly  represented more within this population.  
Significance 
The original contribution of this research was determining variables that might 
influence colorectal cancer screening in people with persistent and severe mental illness 
who received services from a CMH agency. Currently, there is a lack of research related 
to colorectal cancer screening prevention in people with serious and persistent mental 
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illness. As part of the Cochrane Collaboration, a study was conducted to determine the 
effectiveness of interventions targeted at adults with serious mental illness and/or health 
care providers working with this population, in order to find out what interventions were 
taking place that increases cancer screening. There were no randomized controlled trials 
providing evidence as to which method to use in order to increase cancer screening in 
people with severe and persistent mental illness (Barley, Borschmann, Alter, & Tylee, 
2013). In a study of 16,087 people without mental illness, more people completed the 
sample method as opposed to the scope however, the scope method found more cancer 
(American Family Physician, 2013). Therefore, this research could add to the body of 
knowledge for this population on this topic. It might also increase awareness of a need for 
preventive health care as part of a comprehensive model of patient care for people 
receiving treatment form a CMH agency. Use of the Psychiatric Registered Nurse might 
also play a role in regard to patient education and preventive recommendations.  
The results of this study may also encourage innovative medical care systems to 
encourage colorectal screening procedures, such as Integrated Health Care and Person 
Centered Plans which address preventive healthcare. Integrated Health Care is in its 
infancy; it lacks evidence-based research as to the effectiveness of various models of 
integration. By better understanding the variables that might prevent completion of 
colorectal cancer screening, Integrated Health Care models can incorporate changes as 
recommended and identified through this research. The proposed study will potentially 
identify an agenda whereby healthcare workers could best focus their attention and 
increase screening compliance among mentally ill populations.  
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An example of using the Person Centered Plan to increase colorectal cancer 
screening would be to include preventive health care screenings as one of the medical 
goals for someone aged 50-75. The medical goal could be worded as, “I will call my 
insurance company to arrange transportation to see my medical provider” or “If my 
doctor schedules colorectal cancer screening by colonoscopy, I will call my brother to 
take me” or “I will ask my medical provider if I need crc screening.”  On a broader scale, 
the agency can inform and teach patients how to use Medicaid’s transportation services 
or other resources for medical visits in order to request a colorectal screening. However, a 
loved one or family member would need to provide transportation for the colonoscopy 
itself and remain with the person for the duration of the test and recovery. Helping the 
person process who could accompany him or her would be of great benefit. One of the 
variables examined in this research was whether clients need help in understanding the 
complex preparation for colonoscopy cancer screening. If clients required additional 
explanation, a Psychiatric Registered Nurse could be integrated into the Person Centered 
Plan in order to make sure that the person understands how to do the preparation. A Peer 
Advocate might be the only person available to take the person to and from the 
colonoscopy procedure. Providing patients with the FOBT kit with information on how to 
use and checking in with the client to make sure the test is completed is another example 
of how this information might help increase compliance with any cancer screening.  
The Psychiatric Registered Nurse could also play a role in the overall 
development of the medical portion of every person’s plan, by identifying the need for 
colorectal cancer screening and informing the client. This means that it is important for a 
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yearly nursing assessment, which includes who needs preventive healthcare education 
and recommendations for screenings. Embarrassment and anxiety might be an additional 
consideration that the Psychiatric Registered Nurse could attempt to reduce 
embarrassment, and quell anxiety, with the patient while discussing reasons for the test. 
This research was also designed consider race and gender as possible variables of 
colorectal cancer screening completion. An alert to disparities in colorectal cancer 
completion depending upon gender and/or race, is rationale for closer attention to specific 
sub-populations, which might be at higher risk. For example,  gender or race specific 
media could be incorporated into CMH programs for colorectal cancer screening 
awareness.  
 Disparities in medical care for people with mental illness are well documented; 
however, there needs to be more research on barriers to colorectal cancer screening 
completion in people with serious and persistent mental illness, specifically those who 
receive services from a CMH agency. By better understanding these barriers, Health 
Integration Models of care can incorporate ways to improve completion of preventive 
care. More importantly, because colorectal cancer screening requires transportation and 
an elaborate preparation, identified barriers might also apply to other preventive tests 
such as mammograms, cervical cancer screening, skin cancer, and so forth. This research 
may highlight the need for preventive care to be part of Health Integration Models of care 
and the Person Centered Plan where medical needs are concerned.  
Findings of this study could also impart knowledge to mental health providers and 
medical providers whether or not barriers exist in completing colorectal cancer screening 
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and if present, ways to remedy them. Obviously, this is just one study on this population 
group however; it could add to the body of knowledge on this topic and hopefully 
promote further studies. Positive social change could occur when people understand 
barriers to completion of preventive screenings and use that information for Health 
Integrated programs, which are the wave of the future for CMH agencies, due to being 
mandated by insurance carriers and governmental agencies. Medical providers working 
in Patient Centered Medical Homes could benefit from recognition of variables, which 
may prevent colorectal cancer screening from taking place in people with mental illness. 
For CMH agencies in particular, this information could help to form a model of care 
where completion of preventive health care is considered a mandatory part of a Person 
Centered Plan. All CMH patients have a Person Centered Plan that addresses personal 
and health related goals. The Case Manager who develops the treatment plan with the 
client, could include ways to prevent barriers to cancer screening, specifically colorectal 
cancer screening due to the complexity of the preparation for the test. Full use of the 
Psychiatric Registered Nurse could occur should it turn out that the nursing assessments 
do not address preventive health care through recommendations and patient education.  
Summary 
Colorectal cancer is the third most common cancer, representing a significant 
portion of new cancer diagnoses per year (American Cancer Society, 2015). While 
colorectal cancer is relatively treatable so long as it is detected in its early stages, those 
with mental illnesses may be less likely to receive screenings and diagnoses, and more 
likely to die from colorectal cancer (Baillargeon et al., 2011). The purpose of this 
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quantitative study is to identify variables that affect the probability of completion of 
colorectal cancer screening by mentally ill subjects who obtain mental health care from a 
CMH agency. Chapter 1 provides an introduction to the proposed study, including an 
overview of background, methodology, and the significance of the study. Chapter 2 
provides a more thorough investigation of the literature related to the topic, to highlight 
the gap in literature and demonstrate the necessity, of the proposed study. Chapter 3 
outlines the research methodology and data collection and Chapter 5 details results along 
with implications for social and clinical change. 
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Chapter 2: Literature Review 
Introduction 
There is a preponderance of literature about disparities in medical wellbeing and 
loss of lifespan for patients with mental illnesses, highlighting the need for additional 
attention from mental health and medical care providers for people with mental illnesses 
(Lawrence et al., 2013; Musuuza et al., 2013; Viron & Stern, 2010). Recommended 
solutions to this problem include increased involvement by Psychiatric Nurses (Scott & 
Happell, 2011) and Integrated Health Care systems that combine medical care with 
community mental health care (Colton & Manderscheid, 2006). Other suggestions 
involved integrating Case Managers, typically social workers with a bachelor’s degree, to 
help coordinate medical care. Peer Advocates who are former or current patients at the 
CMH agency have also been used to assist individuals with obtaining and complying 
with recommended medical care.  
Cognitive impairments that often accompany a serious mental illness necessitate 
additional help such as completing test directions properly (Lawrence & Kisely, 2010). 
Currently, the U.S. health system is very fragmented, resulting in unmet treatment needs 
and decreased health (Croft & Parish, 2012). Although survival rates are high with early 
detection,  colorectal cancer screening is frequently ignored, resulting in 60% of cases 
remaining undiagnosed until later stages (American Cancer Society, 2014). This lack of 
completion may be due to the intensive preparation and controversy regarding methods of 
screening (Beydoun & Beydoun, 2007). Kold et al. (2010) demonstrated that persons 
with higher instances of primary care visits, such as patients with mental illnesses, are 
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more likely to be referred for screening. However, treatment or diagnostic overshadowing  
mitigates this increased instigation of early detection among those with mental illnesses 
(Henderson et al., 2011; Howard et al., 2010).  
This  research examined potential barriers to colorectal cancer screening in hopes 
that identified barriers to this type of screening for those with mental illness might apply 
to other preventive screenings. Beydoun and Beydoun (2007) evaluated 37 published 
research articles pertaining to barriers to colorectal cancer screening, finding that none of 
these studies took into consideration the special needs of people with mental illness or 
people with mental illness who received care from a CMH agency. Once barriers to 
preventive healthcare are identified, this information can be used as part of a 
comprehensive health integration model of care at a CMH agency or a primary medical 
provider’s practice. The goal of this research was therefore to determine which variables 
help to predict whether or not people with mental illness who obtain care from a CMH 
agency complete colorectal cancer screening. 
This review of the literature on people with mental illness and colorectal cancer 
screening begins with a discussion of disparities in life expectancy, medical care, and 
cancer prevention. This followed by a synopsis of the HBM’s relationship to this study 
and the controversy surrounding recommendations for colorectal cancer screening. Based 
on the findings from this search, my review of the literature on people with mental illness 
and colorectal cancer screening will first highlight the Health Belief model; this general 
overview will be followed by a discussion of disparities between those with mental 
illnesses and the general population in terms of life expectancy, medical care, and cancer 
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prevention. Subsequently, colorectal cancer and screening are discussed explicitly, 
followed by barriers to screening for colorectal cancer, including mental illnesses. The 
literature review attempts to gather information that answers the central research 
question, “What are the variables that determine colorectal cancer screening 
completion?”  
Literature Search Strategy 
 In order to gather literature relevant to the proposed study, I consulted multiple 
general and specific databases related to the topic at hand, including Google Scholar; 
MedScape; MedLine; and the websites for the American Cancer Society, Centers for 
Disease Control and Prevention, and gastroenterology specializations. Search terms 
queried included cancer prevention; screening; colorectal cancer; and disparities in 
colorectal cancer treatment and prevention. All search terms were surveyed alone and 
with the limiter mental illness. After key authors in the field were determined based on 
the initial search, I conducted a final search to determine whether additional pertinent 
articles were available by these seminal researchers, which returned no additional search 
results with relevant data. After discarding 15 articles due to lack of relevance, being out 
of date, or methodological issues, the combined results from Google Scholar, MedScape, 
and Medline consisted of 57 peer reviewed, scholarly articles that were published within 
the last 10 years; I synthesized the relevant data from these studies for my own literature                                                                                        
review. Additional demographic and statistical data from U.S. government reports, the 
Michigan Department of Health, and the American Cancer Society returned an additional 
10 sources that provided information essential to understanding the problem under study. 
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Finally, three seminal works on the HBM, created the theoretical framework for the 
proposed study, which augmented the literature review.  
Theoretical Framework 
HBM  
The theoretical framework for this study is the HBM. The HBM attempts to 
predict health behaviors and to explain them (Conner & Norman, 1996). Hochbaum, 
Rosenstock, and Kegles developed the HBM in the 1950s for the United States Public 
Health Service. In the 1970s, Rosenstock and Becker updated the model to its current 
instantiation used for this research (Rosenstock, 1974), determining that a person will 
comply with health related action in the event that he or she assesses the disease as 
preventable, that a particular action will prevent that disease, and that he or she will be 
successful in implementing that action (Conner & Norman, 1996). The predictive model 
has been used for preventative health behaviors, sick role behaviors, and clinical use. The 
constructs of the model included perceptions of the following: risk of getting the 
condition, seriousness of the condition and consequences, barriers, benefits, cues to 
action, and self-efficacy (Glanz, Rimer, & Viswanath, 2015).  
This model for healthcare in relation to colorectal cancer screening can be 
synthesized as follows: 
• Perceived Susceptibility:  The risk of colorectal cancer and knowledge of this 
risk. Is the risk high enough to do anything about it? What are my chances of 
getting this disease? 
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• Perceived Severity:  How will my life change if I get cancer? Do I have it now 
and not know it?  
• Perceived Barriers:  I’m embarrassed to have this test done. I can’t take the bus or 
a cab to the appointment. I can’t get anyone to go with me. I don’t understand the 
preparation for the test. I can’t get to the store to buy the product recommended. 
This test might hurt and the prep might make me sick. 
• Perceived Benefits:  I might be able to prevent colorectal cancer. I won’t have to 
worry about this for a long time after the test is done. My loved ones want me to 
get it done and my medical provider recommended it due to risk factors. One of 
the variables being tested is whether or not a person understands the need for 
colorectal cancer screening. Embarrassment as a potential barrier will also be 
studied.  
• Cues to Action:  A medical provider recommended that this test be done and my 
family wants me to get it done as well. 
• Self-Efficacy:  Am I confident in my ability to do the test and to do it correctly?  
Understanding and being educated on the colonoscopy preparation is another 
variable being evaluated. Transportation is another factor in being self-sufficient. 
For colonoscopies, transportation and having someone present during the 
procedure might also be a variable affecting colorectal cancer screening 
completion.  
The research questionnaire aligns with research hypothesis as follows: 
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• Perceived Benefits, Susceptibility, and Severity:  Survey questions 13 through 17 
with variables that include preference on type of test resulting in completion of 
screening, acquisition of screening at proper age, and symptoms prompting 
screening.  
• Perceived Threats (Barriers): Survey questions 7 through 10 with variables that 
include embarrassment, fear of pain, fear of cancer, and anxiety. 
• Cues to Action: Survey questions 2, 3, 5, 6, 11and 22 with variables that include 
being told to get the screening, type of screening that increases compliance, 
completing testing when asked, symptoms prompting testing, knowing someone 
who had colorectal cancer, and compliance based upon who asked the person to 
get the testing done. 
• Self-Efficacy: Survey questions 1, 4, and 12 with variables such as transportation, 
physical ability to complete screening, and being able to understand the procedure 
preparation. 
• Modifying Variables: Survey questions 18-21 which are demographics and the 
role they play on completion of colorectal cancer screening such as age, gender, 
race, and education level. 
For the purpose of this study, all of these factors were examined to determine 
their effects on patients’ likelihood to receive colorectal cancer screening. In addition, I 
examined the data to determine whether a difference exists in these variables when 
patients with and without mental illnesses are examined, based on researchers’ assertions 
that there is a disparity in health care for people with mental illnesses. This model was 
30 
 
chosen because it provided a comprehensive and validated understanding of patient 
behavior, which may provide insight to colorectal cancer screening among patients with 
mental illnesses.  
 Disparities in Life Expectancy for People with Mental Illnesses 
In 2008, it was estimated that 46.4% of Americans experienced mental illness and 
those with chronic mental illness would live 15-20 years less than people without mental 
illness 
 
(Kessler et al., 2005; Wahlbeck, Westman, Nordentoft, & Gissler, 2011). Because 
the average life expectancy in the United States of American in 2010 and 2011 was 78.7 
years (Hoyert & Xu, 2012), this suggests that persons with mental illness live an average 
of 58.7 years of age. These statistics cannot solely be blamed on suicide because about 
80% of excess deaths are associated with physical health conditions as opposed to suicide 
(Lawrence, Hancock, & Kisel, 2013).  
Lifestyle, poor financial status, side effects of medication, and inadequate medical 
care are some of the variables that affect the life expectancy of these individuals. Medical 
illnesses accompany psychiatric illnesses by as much as 71% (Lyketsos, Dunn, 
Kaminsky, & Breakey, 2002). Many of the deaths from medical conditions are 
preventable through screening and early detection (Viron & Stern, 2010). The lack of 
screening and preventative care among people with mental illnesses may be contributing 
to the shortened life expectancy (Kessler et al., 2005 and Wahlbeck et al., 2011).  
Disparities in Medical Care for People With Mental Illnesses  
Some authors in the United States have suggested that people with mental 
illnesses received less and lower quality care than those without mental illnesses 
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(Bjorkenstam et al., 2013; Mitchell, Malone, & Doebbeling, 2009). Mitchell et al. (2009) 
reported that disparities in the medical care of people with mental illness have persisted at 
varying magnitudes despite an increase in medical provider contacts. A study of 
6,294,339 individuals in Sweden showed that poorer quality of medical care was received 
by people with mental illness compared to nonmentally ill people with the same medical 
conditions (Bjorkenstam et al., 2013). Bjorkenstam et al. (2013) based this decision in 
part by tracking 72,187 deaths of people with a mental illness and comparing them to 
nonpsychiatric deceased individuals using three quality indicators: the proportion of 
avoidable hospitalizations, case death rate after myocardial infarction and statin use 
among diabetic patients.  
Another example of medical disparities for people with mental illness is the 
higher prevalence of undetected metabolic syndromes and infectious diseases. Rothbard 
et al. (2009) documented this increased prevalence among 656 people admitted to two 
inpatient psychiatric units (Rothbard et al., 2009). Laboratory results showed that 10% of 
these patients had HIV, 32% had Hepatitis B, 21% Hepatitis C, 7% had elevated glucose 
levels, and 22% elevated total cholesterol. The treatment team at the hospital  did not 
know about Hepatitis B in 95% of the patients, 50% of those with Hepatitis C, 21% of 
those with HIV, 89% of people with high cholesterol, 97% of people with high 
triglycerides, and 18% of people with high blood sugar were missed. As with much of the 
literature, however, Rothbard et al. (2009) did not examine whether or not patients were 
aware of these conditions, whether or not the person had healthcare insurance and how 
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many medical provider visits were made in the past year to determine whether the 
primary medical provider was aware of these conditions. 
In short, the specific factors affecting patient care have not been examined to 
determine which barriers have the most effect on the care disparities for those with 
mental illness. Overall, support for disparities in medical care exists for people with 
mental illness and attempts to provide some of the reasons behind this  yet the literature 
has not specifically identified barriers to screening and preventative care. By identifying 
barriers to colorectal cancer screening completion, the goal is  that a diagnosis of colon 
cancer does not continue to be part of the wide range of disparities in medical care for 
people with mental illness.  
Lessening Disparities in Care for People With Mental Illnesses 
In order to provide quality care for all patients, including those who have mental 
illnesses, it is essential to identify barriers to care and to find strategies to overcome those 
barriers. The most pressing, and yet least examined, of these potential barriers is 
diagnostic or treatment overshadowing.  
 Diagnostic or treatment overshadowing. Some researchers suggested that the 
lack of medical treatment in people with mental illness resulted from a condition called 
diagnostic or treatment overshadowing (Henderson et al., 2011; Jones, Howard, & 
Thornicroft, 2008). Diagnostic overshadowing means that a health care professional may 
attribute physical complaints to the patients’ mental illness as opposed to a legitimate 
medical condition (Henderson et al., 2011). Treatment overshadowing suggests that a 
medical provider might not conduct the same treatment for the general population as he 
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or she would for people with learning disabilities, minorities, and people with mental 
illnesses.  
Two studies which showed that people with mental illness and ischemic heart 
conditions were less likely to have cardiac catheterizations than the general public 
exemplified treatment overshadowing (Lawrence, Holman, Jablensky, & Hobbs, 2003; 
Druss, Bradford, Rosenheck, Radford, & Krumholz, 2000). Sullivan, Han, Moore, & 
Kotria (2006) studied admissions in people with diabetes (with and without a mental 
illness) who presented to an emergency department. This study was extensive and used a 
sample size of 4,275 patients over four and a half years. A delineation was made between 
people with schizophrenia or bipolar disorder and those with anxiety and depressive 
disorders. Researchers indicated that those with a mental illness were less likely to be 
hospitalized than those without a mental illness. Those with non-psychotic disorders 
(depression and anxiety) and diabetes were even less likely to be admitted to the hospital 
than the control population. Diagnostic overshadowing was noted in a research study by 
Howard et al. (2010) who suspected blaming physical complaints on the psychiatric 
illness was the reason for a lack of quality medical care and diagnosis of cancer in people 
with mental illness.  
Overcoming diagnostic and treatment overshadowing. Reasons for this 
phenomenon have rarely been researched where mental illness is concerned (Jones et al., 
2008). One study examined emergency room staff and care of people with mental illness 
where diagnostic overshadowing was suspected. Interviews were conducted with 
patients, and a majority thought that their physical symptoms were being seen as part of 
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their mental illness, instead of due to a physical illness. To compensate for diagnostic 
overshadowing, the researchers recommended that psychiatric staff be included in 
emergency room care (Henderson, van Nieuwenhuizen, Kassam, et al. 2011).  
 Kisely et al. (2012) studied mortality among people with mental illness in 
Australia using a large sample of 2,958 people who were ordered to have community 
mental health treatment and 2,958 controls (those with a mental illness who did not get 
treatment from a community agency). Kisely et al. (2012) indicated that people who 
received community mental health interventions had lower mortality rates even three 
years after the study. It was unclear whether or not an integrated medical/psychiatric 
model was in place at that particular community mental health agency. Kisely et al. 
(2012) suggested that treatment orders might help to reduce mortality rates due to 
increased contact with health care professionals. If diagnostic and or treatment 
overshadowing is identified as a barrier to successful healthcare, then these interventions 
may be able to be put in place.  
Perhaps medical providers choosing to work with clients who have mental illness 
are more aware of the needs of this population group. Registered Nurses also work within 
the realms of the CMH setting with the ability to do nursing assessments (which may or 
may not include preventative health care recommendations) and patient education. One of 
the very few studies on Integrated Healthcare that has been published assessed Veteran 
Health facilities that were at the top and bottom of medical quality of care. Kilbourne et 
al. (2012) indicated that in-person contacts with medical providers characterized sites 
with improved patient outcomes, whereas limited communication and stigma for mental 
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illness characterized the least effective sites. Therefore, increased communication, as 
practiced by Integrated Healthcare, could help with the disparities experienced by people 
with mental illness in clinical settings.  
Disparities in Cancer Prevention and Care for People With Mental Illness 
   Some researchers suggested that people with mental illnesses may have an 
increased prevalence of cancer incidence. Pandiani, Boyd, Bank, and Johnson (2006) 
found that the incidence of cancer in people with mental illness is 2.5 times that of the 
general population and in men younger than 50, it is 6.6 times that of the general 
population. Kisely, Crow, and Lawrence (2013) differed by discovering that there was a 
30% higher mortality rate in people with a psychiatric illness even though the incidence 
of cancer was the same as that of the general population. Similarly, Howard et al. (2010) 
reported that diagnostic overshadowing may contribute to the unequal recognition of 
cancer cases in psychiatric patients. In a study of excess mortality from cancer, in people 
with mental illness, Musuuza et al. (2013) pointed out that substance abuse, smoking, and 
hepatitis B and C have a higher prevalence in people with mental illness; however, 
increased mortality could be from late stage identification of disease and inadequate 
treatment of such. Thus, it seems that in addition to the recognition of medical conditions, 
preventive healthcare, particularly screenings for cancer, may also be lacking in mentally 
ill populations. 
Lord, Malone, and Mitchell (2010) did a comparative analysis of people with and 
without mental illness in regard to preventive medical care and screenings. Thirteen 
health domains were used, including colonoscopy, mammograms, and cholesterol 
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screening. Inferior medical care was noted in people with schizophrenia in relation to 
osteoporosis, blood pressure, vaccinations, mammography, and cholesterol monitoring. 
Drus et al (2002) indicated that even with medical provider visits, persons with 
psychiatric disorders (including substance abuse) were at risk for a lower rate of 
preventive services. Preventive cancer screening is especially important in people with 
mental illness because these individuals have been demonstrated as dying of cancer 10 
years earlier than those with cancer who did not have a mental illness (Musuuza et al., 
2013). This fact may be especially observable in cancers for which there is little 
awareness even in the general population, such as colorectal cancer.  
Colorectal Cancer Statistics in the General Population 
      In the United States of America, the lifetime risk of getting colorectal cancer is 1:20; 
it is the second most commonly diagnosed cancer in addition to being the third leading 
cause of cancer deaths (American Cancer Society, 2014). Colorectal cancer screening is 
important because there is a 90% survival rate after 5 years once colorectal cancer is 
detected and treated (American Cancer Society, 2014). Unfortunately, only 4 out of 10 
cases of colorectal cancer are found at the early stages (ACA, 2014). The American 
Cancer Institute (2014) points out that about 50% of people who should get colorectal 
cancer screening do not do so. African Americans have higher colorectal cancer 
diagnosis than other ethnic groups and they also have a lower survival outcome (Hamlyn, 
2008). Jewish people of European descent (Ashkenazi Jews) also have a very high risk of 
getting colorectal cancer due to a hereditary genetic variant (Rosenberg, 2014). A 
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variable being assessed will be whether or not race has any bearing on completion of 
colorectal cancer screening.  
Colorectal Cancer Screening 
 Controversy exists as to whether or not colonoscopies should be the preferred 
screening for colorectal cancer. A colonoscopy requires extensive preparation: adhering 
to a liquid diet the day before the test (nothing with red dye), drinking poor tasting fluids 
in order to clear the bowels which results in diarrhea, and needing someone to take the 
person to the test and home again (American Cancer Society, 2014). A virtual 
colonography through a CT Scan requires the same prep in addition to a tube inserted in 
the rectum to add air in order to obtain pictures of the intestines. If a polyp is found, a 
colonoscopy will need to take place for polyp removal. According to the HBM, extensive 
preparation may damage a patient’s self-efficacy and therefore impede health action 
(Glanz et al., 2015).  
Another test for colorectal cancer screening is the Fecal Occult Blood Test 
(FOBT). For this test, a person merely needs to put a sample of feces on a slide and give 
it to the medical provider or mail it in to a company that does analysis of this type of test 
(Bandi, Cokkinides, Smith, & Jemal, 2011). Ideally a swab from two parts of the same 
stool is put on the glass slide, and the person hopefully did not have any foods containing 
red dye prior to the test. The test is to be repeated at least twice with two different bowel 
movements. If blood is detected, a colonoscopy will need to take place. The Fecal 
Immunochemical Test (FIT) has a preparation similar to the FBOT but does not require 
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any dietary or medication restrictions (Quintero et al., 2012). Again, if something is 
found in this test, a colonoscopy needs to take place.  
There are pros and cons to the various tests in relation to comfort for the patient 
and accuracy but it appears that if a problem is found then a colonoscopy is usually 
recommended (Quintero et al., 2012). The United States Preventive Services Task Force 
website was consulted regarding the status of preferred colorectal cancer screening tests 
and at this time, a change in standards is taking place through research designed to 
determine which test is the preferred test (U.S. Preventative Services Task Force, 2008). 
This finding highlighted the need for further research in to colorectal cancer screening 
recommendations. Identifying barriers to colorectal cancer screening is still needed so 
that rates of early detection can be increased (ACA, 2014; American Cancer Institute, 
2014). Patient preferences for colorectal cancer screening showed no dominant choice in 
a study of one hundred participants at a family practice medical office. This article 
recommended that medical providers keep in mind patient choice for methods of 
colorectal cancer screening when choosing a test (Leard, Savides, & Ganiats, 1997).  
Barriers and Contributors to Colorectal Cancer Screening 
According to a careful review of literature, no available studies examined the 
factors contributing to colorectal cancer screening in the mentally ill. However, some 
recent studies within populations without mental illnesses identified some contributing 
factors to colorectal cancer screening (Almadi et al., 2015; Ghobadi, Noroozi, & 
Thamasebi, 2016). Using the HBM, Ghobadi et al. (2016) examined 600 men and women 
over the age of 50 living in Bushehr, Iran. Through logistic regression, Ghobadi et al. 
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determined that three aspects of the HBM, self-efficacy, perceived barriers, and perceived 
benefits from treatment, significantly contributed to colorectal cancer screening 
completion (P < .01). A potential limitation of Ghobadi et al.’s study was that the sample 
was from a limited location.  
Almadi et al. (2015) used the HBM in a study of a sample of the general 
population in Saudi Arabia. Almadi et al. assessed attitudes, knowledge, family history of 
colorectal cancer, and behavior willingness to undergo colorectal cancer screening. 
Barriers to colorectal cancer screening included: knowledge of need for colorectal cancer 
screening, access to health care delivery systems, lack of time for those needing 
screening, transportation, financial barriers, fear from getting unwanted results, and 
embarrassment or shame. As with Ghobadi et al.’s (2016) study, Almadi et al.’s findings 
may not generalize to the present study because of significant differences in the samples 
i.e. insurance status, cultural factors, Iranian health care systems, and lack of strictly 
mentally ill subjects.  Unlike Almadi et al. (2015) and Ghobadi et al. (2016), Sohler, 
Jeran, and Franks (2015) addressed the influence of several health belief model variables 
on individuals within the United States; however, the sample still consisted of those 
without mental illnesses. Using secondary observational data from a randomized 
intervention trial, Sohler et al. examined five health belief model variables’ influence on 
colorectal cancer screening completion one year after the trial: screening knowledge, self-
efficacy, stage of readiness, barriers, and discussion with a provider. Sohler et al. 
determined that three of the variables independently predicted screening completion: self-
efficacy, discussion with a provider, and readiness. Together, the factors provided an 
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improved model for predicting colorectal cancer screening within the general U.S. 
population, as represented by the sample (Sohler et al., 2015).  
There is high publicity for women to get mammograms through breast cancer 
awareness events and use of the pink ribbon; however, there is little for colorectal cancer 
aimed at any gender. Molina et al. (2004) reported that only 12.3% of women receiving 
mammography who were eligible for colorectal cancer screening were current. For those 
getting healthcare through a community low-income medical center, a mixed study of 23 
people and 10 physicians found four themes related to colorectal cancer screening:  
“1) Unscreened patients cited lack of trust in doctors as a barrier to 
screening whereas few physicians identified this barrier;  
2) Unscreened patients identified lack of symptoms as the reason they had 
not been screened;  
3) A doctor's recommendation, or lack thereof, significantly influenced 
patients' decisions to be screened;  
4) Patients, but not their physicians, cited fatalistic views about cancer as a 
barrier. Conversely, physicians identified competing priorities, such as 
psychosocial stressors or comorbid medical illness, as barriers to screening 
(Lasser, Avanian, Fletcher, & DelVecchio, 2007).”  Although this study 
was small, it was pertinent to note the concern of medical providers on 
variables other than routine cancer screenings which, as listed previously, 
supports the multitude of comorbid medical conditions in people with 
mental illness.   
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The patients’ number of visits has been a metric of determining efficacy for 
cancer treatment. In the general population, Ferrante et al. (2013) noted that colorectal 
cancer screening increases with higher use of primary care provider appointments, and 
Sohler et al. (2015) similarly found that discussions with a care provider increased the 
likelihood that a person would receive colorectal cancer screening. Conversely, 
Lyratzopoulos et al. (2013) analyzed data from the National Audit of Cancer Diagnosis in 
Primary Care 2009-10 to determine the usual number of symptomatic medical visits 
before someone was diagnosed with cancer and referred to a specialist. In Lyratzopolous 
et al.’s study, the authors concluded that the number of visits was inconsequential, and 
the researchers suggested that research and policy initiatives be used to improve the 
sensitivity of symptom appraisal by general practitioners to detect cancer symptoms. 
Meissner, Klabunde, Breen, & Zapka (2012) had primary care providers identify barriers 
to colorectal cancer screening and found that tests were not done despite being 
recommended because of patients’ inability to pay and patients not considering colorectal 
cancer a threat. Two of these variables were  tested in this quantitative study (i.e., “What 
is the relationship between understanding why colorectal cancer screening is needed and 
completion of the test?” and “What is the relationship between gender and completion of 
colorectal cancer screening?” 
Mental Illness and Colorectal Cancer Screening  
Kold et al. (2010) examined 855 veterans at a Veterans Affairs Medical Center 
with and without psychiatric illnesses and determined that veterans with mental health 
diagnoses were significantly less likely to receive screening for colorectal cancer than 
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those with a similar number of outpatient visits but without a psychiatric diagnosis. 
Friedman, Puryear, Moor, & Green (2005) performed a multivariate analysis on 196 
women with psychiatric illness making routine medical visits. Friedman et al. (2005) 
indicated that physician recommendations according to screening guidelines are of 
utmost importance in this population particularly for breast and colorectal cancer. 
Because of the discrepancy in the literature regarding the different medical treatment of 
people with and without mental illnesses, one of the variables being tested for this 
particular research study is whether or not the person was advised to get colorectal cancer 
screening. 
Deficiencies in the Data 
Overall, this study could help to explain whether or not people with mental illness 
are aware of the importance of colorectal cancer screening, whether or not it has been 
recommended by a medical provider, if colorectal cancer screening actually took place 
and barriers to colorectal cancer screening. In addition, I examined whether or not a 
health assessment by a CMH Registered Nurse included colorectal cancer screening 
recommendations during treatment. Because Integrated Healthcare (medical and 
psychiatric) is so new, it is hoped that this research will help CMH agencies take in to 
consideration the importance of colorectal cancer screening, develop ways to increase 
rates of test completion, and utilize the yearly health assessment as a tool for preventive 
healthcare recommendations, especially for patients with mental illnesses.  
Colorectal cancer screening was chosen because it is the most complex and 
difficult screening test to obtain, and thus the most potentially damaging based on the 
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HBM. More research could be conducted to find out whether or not barriers to colorectal 
cancer screening apply to other preventive tests such as mammograms. Currently, there 
are no studies about colorectal cancer screening barriers in people with mental illness. 
Summary 
 Patients with mental illnesses experience deficient medical attention (Bjorkenstam 
et al., 2013; Rothbard et al., 2009), perhaps resulting in the increased rates of early death. 
Similarly, colorectal cancer, though one of the most common types of cancer, remains 
undetected in a majority of cases until past the early stages (American Cancer Society, 
2014). The HBM may provide guidance for understanding the decreased rates of 
colorectal cancer screening completion. While Kold et al. (2010) noted that increased 
primary care visits may improve a patient’s likeliness of receiving a referral for 
screening, these effects may not be felt in the mentally ill population despite their 
increased rates of primary care visits, due to prejudices by primary care providers, 
including diagnostic or treatment overshadowing (Howard et al., 2010). The proposed 
research will examine potential barriers to colorectal cancer screening in hopes that 
identified barriers to this type of screening for those with mental illness might improve 
the rates of preventive screenings for this population. 
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Chapter 3:  Methodology  
Introduction 
 This research was written, in order to determine which variables might influence 
colorectal cancer screening completion, in people with persistent and severe mental 
illness, who received services from a CMH agency. The following chapter outlines the 
design method, as well as the research population, sampling procedures, and 
operationalization of research variables. This chapter also delineates the instrumentation, 
data analysis, informed consent, and threats to validity.  
Research Design and Rationale 
 This research utilized a quantitative, correlational survey design. A quantitative 
method, seeks to examine for statistically significant effects or relationships, between 
quantifiable constructs (Howell, 2010). One of the limitations of a quantitative design is 
that it will not fully examine the underlying perceptions and experiences that a qualitative 
design could provide. In addition, quantitative designs usually employ the use of 
questionnaires or archival data. Due to the nature of this study and the need to safeguard 
anonymity, a qualitative approach with personal interviews and observations, would not 
provide the dependability or credibility of anonymous survey tools. I chose a survey 
design because the participants were asked to complete a series of questionnaires and 
their response was analyzed in an economic and practical manner. I specifically chose a 
correlational survey design because this is used to assess the relationships between 
variables (Creswell, 2005). Correlation designs indicate where associations exist, but do 
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not provide causation. As a result of these decisions, I conducted a quantitative, 
correlational, survey design.  
 The focus of this study was to investigate the effect that these independent 
variables had on completing colorectal cancer screening. The independent variables 
corresponded with access to transportation, being told to get colorectal cancer screening, 
understanding the colonoscopy preparation, being physically able to do the preparation, 
understanding why colorectal cancer screening is needed, embarrassment, gender, race, 
and age. The dependent variables corresponded to having completed colorectal cancer 
screening. Each of these concepts was measureable through responses to a survey 
instrument.  
Target Population 
 The population of interest for this research were CMH clients. The sample 
consisted of 377 individuals ages 50-70 (see sample calculation below), who received 
treatment at an east- and at a west-side CMH office in Detroit, Michigan. The State of 
Michigan’s latest demographic information on people getting mental health services from 




Michigan-Wide Demographic Information for Individuals Receiving Care From a CMH 
Demographic n % 
   
Gender   
 Male 98,902  
 Female 99,537  
Age   
 27 – 64 119,999  
 65 - 70 8,839  
Ethnicity   
 White  58.00% 
 African-Americans  23.00% 
 Asian  0.03% 
 Native Hawaiian or other Pacific islander  0.03% 
 Hispanic or Latino  3.92% 
 Multiracial  5.00% 
 Other race  2.88% 
Housing   
 With relatives  48.78% 
 Private residence without relatives  30.17% 
 Homeless shelter or homeless  4.12% 
 Specialized residential  2.35% 
 General residential  2.01% 
 Supported independent living program  1.08% 
Total household income   
 Below $10,000  53.51% 
 $10,001 - $20,000  13.77% 
 $20,001 - $30,000  3.90% 
 $30,001 - $40,000  1.45% 
 $40,001 - $50,000  0.98% 
 Income over $60,000  0.63% 
 Unreported  25.76% 
Insurance   
 Medicaid  65.21% 
 Medicare  19.51% 
 Commercial health insurance  8.62% 
Employment   
 Full-time  3.82% 
 Part-time  5.49% 
 Unemployed and looking for work  22.80% 
 Homemaker  60.79% 
Education   
 Less than high school  17.63% 
 High school completion   28.78% 
Note. Adapted from Report for Section 404, Community Mental Health Service Programs 





 Diagnosis was not part of this data set, nor was diagnosis elicited for this research 
due to too many confounding variables impacting accuracy. For example, when a patient 
is given an initial assessment, one diagnosis may be given but as more information 
becomes available over time, the diagnosis may change several times. Individuals under 
ages 75 years were not included in the data set. Overall, the majority of people served 
were equally male and female, living with relatives or someone else in a private 
household, had a total household income of less than 10,000 dollars, were unemployed, 
and have Medicaid.  
Sampling and Sampling Procedures 
 To gather participants from the aforementioned population, I gained permission 
from a CMH agency in order to administer surveys to patients (Appendix X). Due to the 
purposive targeted sample, a convenience sampling method was used to collect 
participants from the two centers. Using this sampling method, it was important to 
contact a pool of individuals larger than the necessary sample size as calculated for data 
analysis. This was done so that unfinished or bizarre responses could be discarded 
without affecting the statistically recommended minimal sample size. Each participant 
must have been a patient at one of the two corresponding centers. Individuals were 
required to be between 50-70 years old and must not have had a legal guardian. All of the 
participating individuals must have had insurance to avoid variables of the uninsured.  
According to a study by the National Adult Literacy Survey, about 47% of 
Detroiters are illiterate (Detroit Literacy Coalition, 2008). Therefore, questions were 
worded using easily-understood language and a photo was used to explain colorectal 
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cancer screening. A sign was put up in each lobby, requesting volunteers who met the 
criteria, to fill out the questionnaire. The questionnaire was put on a clipboard at a table 
in each lobby, which allowed privacy when writing results so that the person doesn’t 
have to complete the form at a table next to others (Appendix Z). Strict adherence to the 
university and governmental guidelines for research participation were enforced. No 
names or identifying data were recorded. A locked box was made available where 
participants could place the completed surveys.  
Sample Size Requirement 
 Tabachnick and Fidell (2012) suggested using the formula n > 50 + 8(m) to 
generate the minimum required sample size. Within the formula, m corresponds to the 
number of predictors and n corresponds to the minimum sample size. With a total of 8 
predictors being used in the study, I used Tabachnick and Fidell’s (2012) formula to 
calculate that 114 participants would need to be gathered to justify empirical validity.  
Procedures for Recruitment, Participation, and Data Collection 
 After gaining permission from the CMH agency, I placed a flyer in each lobby, 
requesting volunteers who met the criteria to fill out the survey. The questionnaire 
(Appendix D) was placed on a clipboard at a table in each lobby, which allows privacy 
when writing results. The voluntary nature of the study was explained to participants and 
withdrawal was permitted at any time during the course of the survey. Prior to 
completing the survey questionnaire, a consent form was provided to participants 
(Appendix C). The consent form clearly indicated that care and treatment of any 
individual would not be affected by participation or lack thereof, in the study.  
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 The survey took approximately 5 minutes to complete. Demographic information 
regarding age, race, gender, education level, and type of insurance were gathered. 
Identifying information such as name, phone number, or address were not collected 
during the process. Following the demographic section, participants were asked to 
complete a series of questions about the colonoscopy procedure regarding: prior 
knowledge, previous experience, physical capability, having transportation, and potential 
embarrassment from procedure. A locked box was made available where participants 
could place their completed surveys. At no time was I made aware of who did or did not 
complete the survey; there were also no follow up requirements of the survey 
participants.  
Pilot Study 
I utilized a pilot study to assess the appropriateness of the self-created 
colonoscopy questionnaire. The pilot study was done to make sure that participants were 
accurately interpreting the questions. If interpretation appeared to be problematic, a 
rewording was done. For example the use of stool sample was replaced with poop per the 
request of reviewers, many of whom have worked with this population for over twenty 
years. Once the methodology of the research design and approach were justified, then the 
full study was conducted. The results of the data from the pilot study would remain 
independent from the findings of the complete data set.  
A pilot (feasibility) study is a preliminary investigation to collect data and assess 
the logistics of the data analysis procedures prior to the full study being conducted. Pilot 
studies are typically applied to improve the efficiency and overall quality of the study. 
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While conducting a pilot study, possible drawbacks and deficiencies in the data collection 
and data analysis procedures may be evident (Creswell, 2009). These limitations can be 
fixed by placing more resources, time, and money towards the full study.  
Instrumentation 
 The participants completed a voluntary questionnaire. The self-created instrument 
had not been tested for reliability or validity; thus, an expert panel was employed to 
provide content, construct, and consensual validation of the instrument using agency staff 
familiar with the clientele. Degrees of staff included: Bachelor in Social Work (BSW), 
Master’s in  Social Worker (MSW), Psychiatrists (DO and MD), Bachelor in Nusring 
(BSN), and Master’s in Psychology (LLP) who read and critiqued the instrument in order 
to assess whether or not verbiage of the questionnaire was adequate in order to establish 
the various validations. There were no factors or composite scores being generated, thus I 
did not calculate internal consistency coefficients, per Creswell (2012). To justify the 
reliability of the instrument, a split-half reliability was conducted where the questionnaire 
was split in two sections, and the responses for each section of the test were compared, in 
alignment with Feldt and Brennan (1989). The pilot study was used to ensure that the 
participants were interpreting the questions accurately. Appendix Z contains the survey 
tool that was administered to participants.  
Operationalization 
 The key variables in this quantitative correlational study corresponded to having 
completed colorectal cancer screening, transportation, being told to get colorectal cancer 
screening, understanding the colonoscopy preparation, being physically able to do the 
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preparation, understanding why the colorectal cancer screening is needed, 
embarrassment, gender, race, and age. Operationalizations of these variables are defined 
below. 
Dependent Variables 
Completed colorectal cancer screening:  Dichotomous variable (yes/no) 
corresponding to having completed colorectal cancer screening by colonoscopy. 
Having colorectal cancer in the past or currently: Dichotomous variable (yes/no) 
corresponding to having completed screening.  
Independent Variables 
Access to transportation: Dichotomous variable (yes/no) corresponding to 
individual’s ability to have someone willing to drive them to the facility, stay with the 
person during the cancer screen, and take them home. 
Being told to get colorectal cancer screening:  Dichotomous variable (yes/no) 
corresponding to individual being advised to receive CRC screening.  
Being physically able to do the preparation: Dichotomous variable (yes/no) 
corresponding to individual’s ability to complete the prep which in involves clear liquids 
and diarrhea.  
Understanding why colorectal cancer screening is needed:  Dichotomous variable 
(yes/no) corresponding to individual understanding why the colorectal cancer screening is 
necessary.  
Embarrassment: Dichotomous variable (yes/no) corresponding to individual 
experiencing feelings of embarrassment over the colonoscopy procedure.  
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Fear of pain:  Dichotomous variable (yes/no) corresponding to individual 
experiencing feelings of embarrassment over the colonoscopy procedure.  
Completion of FOBT procedure:  Dichotomous variable (yes/no) corresponding 
to individual completing the FOBT procedure. 
Symptoms of colorectal cancer:  Dichotomous variable (yes/no) corresponding to 
individual demonstrating symptoms of colorectal cancer. 
Anxiety:  Dichotomous variable (yes/no) corresponding to individual being 
anxious over the colonoscopy procedure. 
Recommendation for cancer screening:  Categorical (nominal) variable 
corresponding to individual who recommended participant to undergo cancer screening. 
Fear of cancer diagnosis:  Dichotomous variable (yes/no) corresponding to 
individual being fearful of receiving a diagnosis for cancer during the procedure. 
Race:  Categorical (nominal) variable corresponding to an individual’s ethnicity 
or race were be measured in the demographic portion of the survey. 
Gender:  Categorical (nominal) variable corresponding to an individual’s gender 
were measured in the demographic portion of the survey. 
Age:  Continuous variable corresponding to an individual’s age were measured in 
the demographic portion of the survey. The age range is 50-75. 
Education:  Ordinal variable corresponding to an individual’s education level 
were measured in the demographic portion of the survey. 
Knowing someone who had/has colorectal cancer: Categorical (nomoinal) 
variable corresponding to completion of colorectal cancer screening.  
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Data Analysis Plan 
 Data were compiled into SPSS version 22.0 for Windows. Descriptive statistics, 
frequencies, and percentages were analyzed to describe the trends of the research 
variables. Descriptive statistics were presented to describe the sample demographics and 
the research variables used for the analyses. Frequencies and percentages were calculated 
for any nominal (i.e., categorical) variables of interest. Means and standard deviations 
were calculated for any continuous (i.e., scale or ratio) data of interest (Howell, 2010). 
Data were screened for accuracy and missing data. Questionnaires that were not fully 
completed were potentially removed from further analysis and inferential tests.  
Research Questions and Hypotheses 
Research Question 1: What is the relationship between embarrassment, fear of pain, fear 
of cancer, anxiety and completion of colorectal cancer screening? 
• H01: There is no relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
• HA1: There is a relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
Research Question 2: What is the relationship between transportation, physical ability to 
do testing, understanding the preparation for testing and completion of colorectal cancer 
screening? 
• H02: There is no relationship between transportation, physical ability to do 




• HA2: There is a relationship between transportation, physical ability to do testing, 
understanding the preparation for testing and completion of colorectal cancer screening? 
Research Question 3: What is the relationship between demographics (education, age, 
gender, race) and completion of colorectal cancer screening? 
• H03: There is no relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
• HA3:  There is a relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
Research Question 4: What is the relationship between being physically able to complete 
the colonoscopy scope prep and completion of the test? 
• H04: There is no relationship between being physically able to complete the 
colonoscopy scope prep and completing the test.  
• HA4: There is a relationship between being physically able to complete the 
colonoscopy  scope prep and completing the test.  
Research Question 5: What is the relationship between FOBT vs Scope procedures, age 
of first screening, and a diagnosis of colorectal cancer? 
• H05: There is no relationship between FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
• HA5: There is a relationship between, FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
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Research Question 6: What is the relationship between who recommended colorectal 
cancer screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer, and completion of colorectal cancer screening? 
• H06: There is no relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who had 
colorectal cancer and completion of colorectal cancer screening. 
• HA6: There is a relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who had 
colorectal cancer and completion of colorectal cancer screening 
Chi-square Analyses and Point-Biserial Correlation 
 To address the research questions, fourteen chi-squares and one point-biserial 
correlation were conducted preliminarily to determine which variables have a significant 
relationship with completion of colorectal cancer screening. A chi-square is an 
appropriate analysis to use when the research is interested in the strength of a relationship 
or association between two nominal variables (Howell, 2013). The variables of interest 
for the chi-square tests corresponded to: access to transportation, being told to get 
colorectal cancer screening, understanding why the colorectal cancer screening is needed, 
being able to physically tolerate the prep, fear of pain, completing the FOBT procedure, 
fear of being diagnosed with cancer, having symptoms, individual who recommended 
cancer screening, anxiety, embarrassment, gender, education, and race. The chi-square 
analysis was assessed between the aforementioned variables and the dependent variable – 
completion of colorectal cancer screening. A point-biserial correlation was conducted to 
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assess the relationship between age and completion of colorectal cancer screening. A 
point-biserial correlation (rpb) is an appropriate analysis when the goal of the research is 
to evaluate whether a significant relationship exists between a continuous variable and a 
dichotomous variable (Pallant, 2013).  
 Prior to analysis, the assumptions of chi-square were assessed. In order for chi-
square to operate ideally, the data must come from random samples and the expected 
frequencies should not be too small. Traditional caution in chi-square examinations is 
that expected frequencies below five should not make up more than 20% of the cells, and 
no cell should have an expected frequency that is smaller than one (Pagano, 2009). 
Another assumption of a chi-square analysis is that observations are independent of one 
another. This means that participants can only contribute one observation to the data set. 
To justify this assumption, the row and column totals should be equal to the number of 
participants (Howell, 2010).  
 To determine significance of the results, the calculated chi-square coefficient (χ2) 
was compared to the critical value coefficient. When the calculated coefficient is larger 
than the critical value, or the p-value is less than the alpha level of .05, a significant 
relationship is indicated. In this case, the null hypothesis could be rejected in favor of the 
alternative hypothesis.  
Binary Logistic Regression 
 After determining which variables had a significant relationship with completion 
of colorectal cancer screening, a binary logistic regression was used to assess the 
collective effect of the independent variables on the dependent variable. A binary logistic 
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regression is an appropriate analysis to use when the dependent variable has two levels 
(i.e. dichotomous), meaning there are only two possible outcomes (Stevens, 2009). The 
independent variable for a binary logistic regression can be continuous, discrete, or a 
combination of continuous and discrete. In this research, the dependent variable 
corresponded to completion of colorectal cancer screening (yes/no). The independent 
variables corresponded to access to transportation, being told to get colorectal cancer 
screening, understanding why the colorectal cancer screening is needed, being able to 
physically tolerate the prep, fear of pain, completing the FOBT procedure, fear of being 
diagnosed with cancer, having symptoms, individual who recommended cancer 
screening, anxiety, embarrassment, gender, education, and race. Only the significant 
nominal predictors indicated by the chi-square analysis were placed into the logistic 
regression model. Using the point-biserial correlation, if age was found to be significantly 
associated with completion of colorectal cancer screening, then this variable was placed 
into the logistic regression model as well. 
 Logistic regressions bypass many of the restrictive assumptions of least-squares 
linear regressions (Tabachnick & Fidell, 2013). Linearity, normality, and homogeneity of 
variance are not assumed. The major assumption of this analysis is that the dependent 
variable needs to be discrete and dichotomous. In addition, the assumptions for removal 
of outliers, absence of multicollinearity, and independence of errors were assessed 
(Tabachnick & Fidell, 2013). 
 The overall model was assessed for the collective effects of the independent 
variables on the completion of colorectal cancer screening, presented with a χ2 
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coefficient. The Nagelkerke R2 was examined to assess for the percent of variance of the 
dependent variable accounted by the independent variables. If the overall model indicated 
significance, the individual predictors were further analyzed. Individual predictors were 
assessed by the Wald coefficient and significance was determined with an alpha level of 
.05.  
Threats to External Validity 
 Key threats to external validity correspond to portions of the sample that provide 
bias towards the situational specifics of the study data collected, the calculated results, or 
a specific researcher. Furthermore, there may have been covariates or confounding 
variables that strengthened or weakened the relationships between the variables of 
interest (Howell, 2010). Because it was not feasible to adjust for every potential 
covariate, this limitation was accepted and acknowledged in the interpretation of the 
results. As a result, I implemented additional caution in the interpretation of the study’s 
results, and did not assume that these results could be perfectly generalized towards the 
population of interest (Creswell, 2005) 
Threats to Internal Validity 
 Several potential limitations exist within the extent of quantitative studies. First, 
quantitative methodologies are able to examine the research questions and subsequent 
hypotheses, however they are not able to fully measure the depth and underlying 
experiences and perceptions of the subjects. As a result, I substituted the degree of 
richness inherent within a qualitative study for a degree of statistical certainty that these 
relationships were not established by chance alone (Pagano, 2009). 
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 In order to attain internal validity, causal inferences must be present. Causal 
inferences can occur when the effect is generated by the cause or when there is no 
feasible explanation for why the effect exists. Consequently, key threats to internal 
validity could occur if the sequence of cause and effect are misinterpreted or if there is 
bias in the selection of the sample.  
Ethical Procedures 
 A researcher conducting a study with human subjects has a responsibility to 
protect and inform (Bloomberg & Volpe, 2012). When conducting this study, I followed 
the moral and ethical guidelines presented by federal regulations and the Institutional 
Review Board (IRB). The following paragraphs provide the proposed approach to 
provide informed consent and a brief discussion on data retention, storage, and 
destruction to protect participant’s confidentiality. 
Informed Consent 
An informed consent was marked with an X by the participant who could 
continue with the survey or not. Because I was also an employee of the agency where the 
study was taking place, efforts were made to make sure that patients were aware that I 
would not know who did or did not complete the questionnaire. A poster was put in the 
lobby with a photo of a colon explaining the procedure. The consent form  explained the 
rest. The questionnaire was put in a secured box by the participant when completed. Any 
questions or concerns about the study were directed to the IRB staff member at Walden 
University. Completing the questionnaire was totally voluntary as they were placed on a 
table with a clipboard and the poster. No identifiable traits or information were used in 
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the data analysis. I remained in another part of the agency or was at a different location 
during the study. 
Data Storage, Retention, and Destruction to Protect Confidentiality 
 The survey instrument for this study was designed to reduce the necessity to 
collect identifiable data. In accordance with federal and IRB guidelines, I safeguarded all 
data and information in order to protect participants’ confidentiality. No names or 
identifying data were collected. The safeguard measure for data storage is a locked file in 
my residence where the data will be retained securely for a period of five years after the 
research is complete. Upon expiration of the five-year retention period, I will 
permanently delete the data. 
Summary 
 The previous chapter outlined the quantitative design, as well as rationale for the 
use of this research model. In addition, a population and subsequent sample were 
delineated and procedures for the gathering of participants were indicated as following a 
convenience sampling method. The chapter also operationalized the variables which were  
used to measure the variables of interest, and included the instrumentation and 
procedures for data collection. The treatment of data and statistical procedures addressing 
the hypotheses are explained, and include a rationale for such analyses along with the 
presentation of results. Finally, limitations and ethical concerns were addressed, with 
special consideration to potential methods which may remedy these difficulties or harms. 
The researcher adhered strictly to these procedures in gathering and analyzing data in 




Chapter 4: Results 
Introduction 
 The purpose of the  esearch was to determine which variables might influence 
colorectal cancer screening completion, in people with persistent and severe mental 
illness, who receive services from a CMH agency. The following research questions were 
examined: 
Research Questions and Hypotheses 
Research Question 1: What is the relationship between embarrassment, fear of pain, fear 
of cancer, anxiety and completion of colorectal cancer screening? 
• H01: There is no relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
• HA1: There is a relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
Research Question 2: What is the relationship between transportation, physical ability to 
do testing, understanding the preparation for testing and completion of colorectal cancer 
screening? 
• H02: There is no relationship between transportation, physical ability to do 
testing, understanding the preparation for testing and completion of colorectal cancer 
screening? 
• HA2: There is a relationship between transportation, physical ability to do testing, 
understanding the preparation for testing and completion of colorectal cancer screening? 
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Research Question 3: What is the relationship between demographics (education, age, 
gender, race) and completion of colorectal cancer screening? 
• H03: There is no relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
• HA3:  There is a relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
Research Question 4: What is the relationship between being physically able to complete 
the colonoscopy scope prep and completion of the test? 
• H04: There is no relationship between being physically able to complete the 
colonoscopy scope prep and completing the test.  
• HA4: There is a relationship between being physically able to complete the 
colonoscopy  scope prep and completing the test.  
Research Question 5: What is the relationship between FOBT vs Scope procedures, age 
of first screening, and a diagnosis of colorectal cancer? 
• H05: There is no relationship between FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
• HA5: There is a relationship between, FOBT vs Scope procedures, age of first 
screening, and a diagnosis of colorectal cancer. 
Research Question 6: What is the relationship between who recommended colorectal 
cancer screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer, and completion of colorectal cancer screening? 
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• H06: There is no relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who had 
colorectal cancer and completion of colorectal cancer screening. 
• HA6: There is a relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who had 
colorectal cancer and completion of colorectal cancer screening 
This chapter includes the findings of the data collection process. Descriptive 
statistics were utilized to examine the trends in variables. Frequencies and percentages 
were be used to explain trends in nominal variables. Means and standard deviations were  
calculated for continuous variables. The research questions were  examined by a 
combination of chi-square analyses, point-biserial correlation, and a binary logistic 
regression. Significance was evaluated at the generally accepted α = .05 
Data Collection 
Frequencies and Percentages of Sample Characteristics 
 Two CMH Departments located in Detroit, Michigan were the sources of the 
sample. A sign was placed in each lobby explaining the colonoscopy procedure and 
another sign asked participants to complete the survey if he or she was a client of the 
agency, did not have a legal guardian, and was aged 50-75 years of age. Clipboards with 
the survey and pens were placed on the table so that I avoided potential conflicts of 
interest from knowing who completed the surveys. The data collection process took 
approximately three weeks to gather enough surveys. Ten surveys were not part of the 
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research due to incomplete or bizarre/non-sensical responses. Overall, the plan for the 
gathering of the research was followed and didn’t need to deviate.  
 A total of 128 individuals participated in the survey. A majority of participants 
were female (n = 93, 72.7%). A majority of participants were African American (n = 
105, 82%). Most participants had only Medicaid insurance (n = 59, 46.1%); however, 
many participants had both Medicaid and Medicare insurance (n = 38, 29.7%). The 
distribution of participants who used the FOBT (n = 52, 46%) and Scope (n = 61, 54%) 
procedures was approximately equal. A majority of participants had completed colorectal 
cancer screening (n = 69, 53.9%). Table 2 presents the frequencies and percentages for 




Frequencies and Percentages for Sample Characteristics 
Variable n % 
   
Gender   
Female 93 72.7 
Male 35 27.3 
Race   
Black 105 82.0 
White 12 9.4 
Other 1 0.8 
No response 10 7.8 
Education    
GED 24 18.8 
Diploma 66 51.6 
Some college 2 1.6 
Bachelors 1 0.8 
      Quit School 35 27.3 
Insurance   
Medicaid 59 46.1 
Medicare 38 29.7 
Medicaid/Medicare 22 17.2 
Missing 9 7.0 
Procedure used   
FOBT 52 46.0 
Scope 61 54.0 
Completed colorectal cancer screen   
Yes 69 53.9 
No 59 46.1 
 
Descriptive Statistics for Age 
 Descriptive statistics were used to examine the range, mean, and standard 
deviation of the participants’ age. Participant ages ranged from 50.00 to 77.00 years old, 
with M = 57.30 and SD = 5.06. A convenience sample was used to survey participants 




Research Question 1 
Research Question 1 asked, “What is the relationship between embarrassment, fear of 
pain, fear of cancer, anxiety and completion of colorectal cancer screening?” 
H01: There is no relationship between embarrassment, fear of pain, fear of 
cancer, anxiety and completion of colorectal cancer screening. 
HA1: There is a relationship between embarrassment, fear of pain, fear of cancer, 
anxiety and completion of colorectal cancer screening. 
 To address Research Question 1, a series of chi-square analyses were conducted 
to examine the relationship between embarrassment, fear of pain, fear of cancer, anxiety 
and completion of colorectal cancer screening. A chi-square analysis is an appropriate 
statistical tool when assessing the relationship between two categorical variables 
(Howell, 2010). Embarrassment, fear of pain, fear of cancer, anxiety, and completion of 
colorectal cancer screening were coded: 1 = yes or 0 = no.  
 Embarrassment. Results of the chi-square indicated significance, χ2(1) = 6.28, p 
= .012, suggesting that there was a significant relationship between embarrassment and 
completion of colorectal cancer screening. Most participants had completed colorectal 
cancer screening and were not embarrassed (n = 64 participants). Results of the chi-
square analysis between embarrassment and completion of colorectal cancer screening 




Chi-Square Analysis for Embarrassment and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Embarrassment Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
 Fear of pain. Results of the chi-square indicated significance, χ2(1) = 7.89, p = 
.005, suggesting that there was a significant relationship between fear of pain and 
completion of colorectal cancer screening. Most participants had completed colorectal 
cancer screening and did not have a fear of pain (n = 57 participants). Results of the chi-
square analysis between fear of pain and completion of colorectal cancer screening are 
presented in Table 4.  
Table 4 
 
Chi-Square Analysis for Fear of Pain and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Fear of Pain Yes No χ2(1) p 











Note. Bracketed values display expected counts for each cell 
 Fear of cancer. Results of the chi-square indicated significance, χ2(1) = 4.21, p = 
.040, suggesting that there was a significant relationship between fear of cancer and 
completion of colorectal cancer screening. Most participants had completed colorectal 
cancer screening and did not have a fear of cancer (n = 59 participants). Results of the 
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chi-square analysis between fear of cancer and completion of colorectal cancer screening 
are presented in Table 5.  
Table 5 
Chi-Square Analysis for Fear of Cancer and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Fear of Cancer Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
 Anxiety and completion of colorectal cancer screening. Results of the chi-
square indicated significance, χ2(1) = 11.40, p = .001, suggesting that there was a 
significant relationship between anxiety and completion of colorectal cancer screening. 
Most participants had completed colorectal cancer screening and did not have anxiety (n 
= 56 participants). Results of the chi-square analysis between anxiety and completion of 






Chi-Square Analysis for Anxiety and Completion of Colorectal Cancer Screening 
 Completion of Colorectal 
Cancer Screening 
 
Anxiety Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cellResearch Question 2: What is the 
relationship between transportation, physical ability to do testing, understanding the 
preparation for testing, and completion of colorectal cancer screening? 
H02: There is no relationship between transportation, physical ability to do 
testing, understanding the preparation for testing, and completion of colorectal 
cancer screening? 
HA2: There is a relationship between transportation, physical ability to do testing, 
understanding the preparation for testing, and completion of colorectal cancer 
screening? 
 To address research question two, a series of chi-square analyses were conducted 
to examine the relationship between transportation, physical ability to do testing, 
understanding the preparation for testing, and completion of colorectal cancer screening. 
Transportation, physical ability to do testing, understanding the preparation for testing, 
and completion of colorectal cancer screening were coded: 1 = yes, 0 = no.  
 Transportation. Results of the chi-square did not indicate significance, χ2(1) = 
0.44, p = .508, suggesting that there was not a significant relationship between 
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transportation and completion of colorectal cancer screening. Most participants had 
completed colorectal cancer screening and did have access to transportation (n = 53 
participants). Results of the chi-square analysis between access to transportation and 
completion of colorectal cancer screening are presented in Table 7.  
Table 7 
Chi-Square Analysis for Transportation and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Access to 
Transportation 
Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
 Physical ability to do testing. Results of the chi-square indicated significance, 
χ2(1) = 5.77, p = .016, suggesting that there was a significant relationship between having 
physical ability to do testing and completion of colorectal cancer screening. Most 
participants had completed colorectal cancer screening and did have a physical ability to 
do testing (n = 61 participants). Results of the chi-square analysis between physical 




Chi-Square Analysis for Physical Ability to do Testing and Completion of Colorectal 
Cancer Screening 
 Completion of Colorectal Cancer Screening  
Physical Ability Yes No χ2(1) p 
     









*Note:  Bracketed values display expected counts for each cell 
 Understanding preparation for testing. Results of the chi-square did not 
indicate significance, χ2(1) = 0.88, p = .349, suggesting that there was not a significant 
relationship between understanding preparation for testing and completion of colorectal 
cancer screening. Most participants had completed colorectal cancer screening and did 
not understand test preparation (n = 57 participants). Results of the chi-square analysis 
between understanding preparation for testing and completion of colorectal cancer 
screening are presented in Table 9.  
Table 9 
Chi-Square Analysis for Understanding Preparation for Testing and Completion of 
Colorectal Cancer Screening 
 Completion of Colorectal Cancer 
Screening 
 
Understanding Test Preparation Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
Research Question 3: What is the relationship between demographics (education, age, 
gender, race) and completion of colorectal cancer screening? 
H03: There is no relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
HA3:  There is a relationship between demographics (education, age, gender, 
race) and completion of colorectal cancer screening? 
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 To address research question three, a series of chi-square analyses and a point-
biserial correlation were conducted to examine the relationship between education, age, 
gender, race, and completion of colorectal cancer screening. A point-biserial correlation 
is an appropriate statistical analysis when assessing the strength of association between a 
continuous variable and a dichotomous variable (Pagano, 2009). Education was a 
categorical variable coded: 1 = GED, 2 = Diploma, 3 = some college, 4 = Bachelors, 5 = 
No response. Age was treated as a continuous variable. Gender was a dichotomous 
variable coded: 1 = male, 0 = female. Race was a categorical variable coded: 1 = Black, 2 
= White, 3 = Other. Completion of colorectal cancer screening was coded: 1 = yes, 0 = 
no.  
 Education. Results of the chi-square did not indicate significance, χ2(4) = 3.94, p 
= .415, suggesting that there was not a significant relationship between education and 
completion of colorectal cancer screening. Most participants had completed colorectal 
cancer screening and had obtained a diploma (n = 35 participants). Results of the chi-
square analysis between education and completion of colorectal cancer screening are 




Chi-Square Analysis for Education and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Education Yes No χ2(4) p 
     






























*Note:  Bracketed values display expected counts for each cell 
 Gender. Results of the chi-square did not indicate significance, χ2(1) = 1.30, p = 
.254, suggesting that there was not a significant relationship between gender and 
completion of colorectal cancer screening. Most participants who had completed the 
colorectal cancer screening were female (n = 53 participants). Results of the chi-square 
analysis between gender and completion of colorectal cancer screening are presented in 
Table 11.  
Table 11 
Chi-Square Analysis for Gender and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Gender Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
 Race. Results of the chi-square did not indicate significance, χ2(2) = 1.17, p = 
.559, suggesting that there was not a significant relationship between race and completion 
of colorectal cancer screening. Most participants who had completed colorectal cancer 
screening were African American (n = 56). Results of the chi-square analysis between 




Chi-Square Analysis for Race and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Race Yes No χ2(2) p 


















*Note:  Bracketed values display expected counts for each cell 
 Age. A point-biserial correlation was conducted to examine the relationship 
between age and completion of colorectal cancer screening. Results of the correlation did 
not indicate significance, rpb = -.15, p = .086. Thus, there is not sufficient evidence for a 
statistically significant relationship between age and completion of colorectal cancer 









Point-Biserial Correlation between Age and Completion of Colorectal Cancer Screening 
 Completion of Colorectal 
Cancer Screening  
  
Age -.15 
Note. * p < .05. ** p < .01. 
Research Question 4:  What is the relationship, between being aware of recommended 
colorectal cancer screening at age 50 and completing the test? 
H04: There is no relationship between being aware of recommended colorectal 
cancer screening at age 50 and completion of the test? 
HA4: There is no relationship between being aware of recommended colorectal 
cancer screening at age 50 and completion of the test? 
 To address research question four, a chi-square analysis was conducted to 
examine the significant relationship between being aware of the recommended colorectal 
cancer screening at age 50 and completion of colorectal cancer screening. Awareness of 
screening at age 50 was coded: 1 = yes and 0 = no. Completion of colorectal cancer 
screening were coded: 1 = yes, 0 = no.  
 Awareness of screening at age 50. Results of the chi-square did not indicate 
significance, χ2(1) = 6.75, p = .009, suggesting that there was a significant relationship 
between awareness of screening at age 50 and completion of colorectal cancer screening. 
Most participants had completed colorectal cancer screening and were aware of screening 
at age 50 (n = 58 participants). Results of the chi-square analysis between awareness of 
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screening at age 50 and completion of colorectal cancer screening are presented in Table 
14.  
Table 14 
Chi-Square Analysis for Awareness of Screening at Age 50 and Completion of Colorectal 
Cancer Screening 
 Completion of Colorectal Cancer 
Screening 
 
Awareness of Screening at Age 
50 
Yes No χ2(1) p 













*Note:  Bracketed values display expected counts for each cell 
Research Question 5: What is the relationship, between FOBT vs Scope procedures, age 
of first screening, and completion of colorectal cancer screening? 
 H05: There is no relationship between FOBT vs Scope procedures, age of first 
screening, and completion of colorectal cancer screening? 
HA5: There is a relationship between, FOBT vs Scope procedures, age of first 
screening, and completion of colorectal cancer screening? 
 To address research question five, a series of chi-square analyses were conducted 
to examine the relationship between FOBT vs Scope procedures, age of first screening, 
and completion of colorectal cancer screening. FOBT vs Scope procedures were coded: 1 
= FOBT and 2 = SCOPE. Age of first screening and completion of colorectal cancer 
screening were coded: 1 = yes, 0 = no.  
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 FOBT vs scope procedure. Results of the chi-square did indicate significance, 
χ2(1) = 14.71, p < .001, suggesting that there was a significant relationship between 
FOBT vs Scope and completion of colorectal cancer screening. Most participants had 
completed colorectal cancer screening and used the Scope procedure (n = 42 
participants). Results of the chi-square analysis between FOBT vs Scope and completion 
of colorectal cancer screening are presented in Table 15.  
Table 15 
Chi-Square Analysis for FOBT vs Scope and Completion of Colorectal Cancer Screening 
 Completion of Colorectal Cancer Screening  
Procedure Used Yes No χ2(1) p 













*Note:  Bracketed values display expected counts for each cell 
 Age of first screening. Results of the chi-square indicate significance, χ2(1) = 
18.49, p < .001, suggesting that there was a significant relationship between age of first 
screening and completion of colorectal cancer screening. Most participants who had 
completed colorectal cancer screening had been screened at age 50 (n = 37 participants). 
Results of the chi-square analysis between age of first screening and completion of 





Chi-Square Analysis for Age of First Screening and Completion of Colorectal Cancer 
Screening 
 
 Completion of Colorectal Cancer Screening  
Screen at 
Age 50? 
Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
Research Question 6: What is the relationship between who recommended colorectal 
cancer screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer, and completion of colorectal cancer screening? 
H06: There is no relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal cancer and completion of colorectal cancer screening. 
HA6: There is a relationship between who recommended colorectal cancer 
screening, being told to get screened, symptoms of cancer, knowing someone who 
had colorectal  cancer and completion of colorectal cancer screening 
 To address research question six, a series of chi-square analyses were conducted 
to examine the relationship between who recommended colorectal cancer screening, 
being told to get screened, symptoms of cancer, knowing someone who had colorectal 
cancer, and completion of colorectal cancer screening. The variable for who 
recommended colorectal cancer screening was coded: 1 = family, 2 = medical person, 3 = 
multiple people, 4 = newspaper/TV, 5 = Other. Being told to get screened, symptoms of 
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cancer, knowing someone who had colorectal cancer, and completion of colorectal cancer 
screening were coded: 1 = yes, 0 = no.  
 Individual(s) who recommended screening. Results of the chi-square did not 
indicate significance, χ2(4) = 2.16, p = .706, suggesting that there was not a significant 
relationship between who recommended cancer screening and actual completion of 
colorectal cancer screening. Most participants who had completed colorectal cancer 
screening were recommended for the screening by a medical person (n = 43 participants). 
Results of the chi-square analysis between individual(s) who recommended screening and 
completion of colorectal cancer screening are presented in Table 17.  
Table 17 
Chi-Square Analysis for who Recommended Screening and Completion of Colorectal 
Cancer Screening 





Yes No χ2(4) p 


























*Note:  Bracketed values display expected counts for each cell 
 Being told to get screened. Results of the chi-square did indicate significance, 
χ2(1) = 39.00, p < .001, suggesting that there was a significant relationship between being 
80 
 
told to get screened and completion of colorectal cancer screening. Most participants who 
were told to be screened, actually completed the colorectal cancer screening process (n = 
67 participants). Results of the chi-square analysis between being told to get screened and 
completion of colorectal cancer screening are presented in Table 18.  
 
Table 18 
Chi-Square Analysis for Being Told to Get Screened and Completion of Colorectal 
Cancer Screening 
 Completion of Colorectal Cancer 
Screening 
 
Being Told to Get Screened Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
 Know someone who had colorectal cancer. Results of the chi-square indicated 
significance, χ2(1) = 4.13, p = .042, suggesting that there was a significant relationship 
between knowing someone who had colorectal cancer and completion of colorectal 
cancer screening. Most participants who had completed colorectal cancer screening did 
not know someone who had colorectal cancer (n = 43 participants). Results of the chi-
square analysis between knowing someone who had colorectal cancer and completion of 




Chi-Square Analysis for Knowing Someone Who Had Colorectal Cancer and Completion 
of Colorectal Cancer Screening 
 Completion of Colorectal Cancer 
Screening 
 
Know Someone Who Had 
Colorectal Cancer 
Yes No χ2(1) p 











*Note:  Bracketed values display expected counts for each cell 
Binary Logistic Regression 
 A binary logistic regression was conducted to examine the predictive relationship 
between the significant predictors from the chi-square analyses and completion of 
colorectal cancer screening. A binary logistic regression is an appropriate statistical 
analysis when the goal of the research is to assess the predictive association between a 
group of predictors and a dichotomous dependent variable (Stevens, 2009). The 
significant predictors entered into the model corresponded to embarrassment, fear of 
pain, fear of cancer, anxiety, physical ability to do testing, awareness of screening at age 
50, FOBT vs Scope procedures, age of first screening, being told to get screening, and 
knowing someone who had screening. The outcome variable corresponded to completion 
of colorectal cancer screening – Yes or No.  
 Prior to analysis, the assumptions of a binary logistic regression were assessed – 
outliers, absence of multicollinearity, and independence of errors (Tabachnick & Fidell, 
2013). Due to the variables of interest all being dichotomous, there were no outliers to 
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identify and the assumption was met. Variance Inflation Factors (VIFs) were used to test 
the absence of multicollinearity assumption, where values greater than 10 suggested a 
violation of the assumption (Stevens, 2009). None of the VIF values in the regression 
model were greater than 10 (largest VIF = 1.96), therefore, the assumption was met. 
Table 20 presents the findings of the Variance Inflation Factors (VIFs). The 
independence of errors assumption was met due to every participant providing 
independent responses. Each response derived from a different, unrelated case.  
 
Table 20 





Fear of pain 1.68 
Fear of cancer 1.73 
Anxiety 1.96 
Physically able to test 1.49 
Awareness of screening at age 50 1.19 
FOBT vs Scope 1.14 
Age of first screening at age 50 1.32 
Being told to get screening 1.20 
Know someone with colorectal cancer 1.12 
  
 
 Results of the binary logistic regression indicated that there was a significant 
association between embarrassment, fear of pain, fear of cancer, anxiety, physical ability 
to do testing, awareness of screening at age 50, FOBT vs Scope procedures, age of first 
screening, being told to get screening, knowing someone who had screening, and 
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completion of colorectal cancer screening (χ2(10) = 69.22, p < .001). The predictors in 
the model collectively accounted for 64.5% of the variance in completing colorectal 
cancer screening. 
 Participants who indicated they were anxious had 8.33 (1/0.12) more odds to not 
have completed colorectal cancer screening in comparison to participants who indicated 
they were not anxious (Wald (1) = 4.31, p = .038). Participants who used the Scope 
method had 5.17 more odds to have completed colorectal cancer screening in comparison 
to participants who used the FOBT method (Wald (1) = 6.73, p = .009). Participants who 
were told to get screening had 59.84 times more odds to have completed colorectal 
cancer screening in comparison to participants who were not told to get screened (Wald 
(1) = 12.68, p < .001). Results of the binary logistic regression are presented in Table 21. 
Table 21 
Results of the Binary Logistic Regression for Significant Variables and Completion of 
Colorectal Cancer Screening 
Source B Wald (1) p OR 95% CI for OR 
     Lower Upper 
       
Embarrassment -0.21 0.03 .858 0.81 0.08 8.16 
Fear of pain 0.43 0.23 .631 1.54 0.26 9.01 
Fear of cancer 0.79 0.55 .457 2.21 0.27 17.79 
Anxiety -2.10 4.31 .038 0.12 0.02 0.89 
Physically able to test 1.59 2.67 .103 4.88 0.73 32.77 
Awareness of screening at age 50 0.39 0.31 .580 1.48 0.37 5.93 
FOBT vs Scope 1.64 6.73 .009 5.17 0.06 0.67 
Age of first screening at age 50 1.37 3.45 .063 3.95 0.93 16.81 
Being told to get screening 4.09 12.68 <.001 59.84 6.29 568.96 
Know someone with colorectal 
cancer 
-0.15 0.04 .837 0.86 0.20 3.71 
       




 The purpose of the proposed research was to determine which variables might 
influence colorectal cancer screening completion, in people with persistent and severe 
mental illness, who receive services from a CMH agency. This chapter presented the 
findings of the data collection and data analyses. Demographic characteristics and 
descriptive statistics were presented first.  
 To examine the research questions, a series of chi-square analyses were conducted 
to examine the cross tabulations between the categorical characteristics of participants 
and completion of colorectal cancer screening. The significant chi-square analyses of 
variables correlated with completion of colorectal cancer screening corresponded to 
embarrassment, fear of pain, fear of cancer, anxiety, physical ability to do testing, 
awareness of screening at age 50, FOBT vs Scope procedures, age of first screening, 
being told to get screening, and knowing someone who had screening. The non-
significant chi-square analyses of variables uncorrelated with completion of colorectal 
cancer screening corresponded to transportation, understanding preparation for testing, 
education, gender, race, and the individual who recommended screening. A point-biserial 
correlation was conducted to examine the relationship between age and completion of 
colorectal cancer screening. The correlation was not significant, suggesting that there was 
not a significant relationship between age and completion of colorectal cancer screening.  
 The significant variables from the chi-square analyses were entered into a binary 
logistic regression. The overall model was significant, suggesting that 64.5% of the 
variance in completion of colorectal cancer screening could be attributed to the 
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predictors. The significant predictors in the model corresponded to Anxiety, FOBT vs 
Scope, and being told to get screening. Participants who indicated they were anxious 
were less likely to have completed colorectal cancer screening when compared to 
participants who indicated they were not anxious. Participants who used the Scope 
method were more likely to have completed colorectal cancer screening when compared 
to participants who used the FOBT method. Participants who were told to get screening 
were more likely to have completed colorectal cancer screening when compared to 
participants who were not told to get screened.  
 In the next chapter, the statistical findings will be discussed further and 
comparisons will be made to existing literature. The findings will be also connected back 
to the theoretical framework selected for the research. Additionally, limitations and 




Chapter 5: Discussion, Conclusions, and Recommendations 
Colorectal cancer is the second leading cause of cancer deaths behind lung cancer. 
(Centers for Disease Control, 2011) About 1 in 20 people  have a lifetime risk of being 
diagnosed with colorectal cancer, causing an estimated 49,700 deaths in 2015 (American 
Cancer Society, 2015). Although rates of colorectal cancer detection are increasing as 
more and more people get preventative screenings, one population that does not show a 
decrease are people with mental illness. An estimated 46.4% of Americans experience 
mental illness in their lifetime; persons with chronic mental illness on average live 15-20 
fewer years than people without mental illness (Kessler et al., 2005; Wahlbeck, 
Westmann, Nordentoft, & Gissler, 2011). In addition to a shorter life span, the incidence 
of cancer in people with mental illness is 2.5 times that of the general public and, in men 
younger than 50 years, 6.6 times the risk than that of the general public (Pandiani, Boyd, 
Bank, & Johnson, 2006). Individuals with mental illness diagnosed with cancer die an 
average of 10 years earlier than those without mental illnesses (Musuuzo et al., 2013). 
Persons over 65 years of age with mental disorders are also more likely to be diagnosed 
with colon cancer only at autopsy, with an unknown stage of cancer, and without having 
received any treatment (Baillargeon et al., 2011).  
By finding variables that increase the likelihood of colorectal cancer screening 
completion, community mental health (CMH) agencies can devise ways to remedy lack 
of colorectal cancer screening that might also increase screenings for other types of 
cancer/illnesses in this population group. Despite an extensive literature search, I did not 
find any studies that specifically addressed variables affecting colorectal cancer screening 
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completion in the CMH population. Thus, the purpose of this quantitative correlational 
survey design study was to identify variables that affect the probability of completion of 
colorectal cancer screening, whether through FOBT/FIT (stool sample) or 
sigmoid/colonoscopy (scope) by people with mental illness who obtain mental health 
care from a CMH agency.  
The results of the correlational analyses showed that several variables were 
significantly related to screening: embarrassment, fear of pain, fear of cancer, anxiety, 
being physically able to complete the test/preparation, awareness of screening at age 50, 
FOBT/FIT vs Scope, age of first screening at 50, being told to get screening, and 
knowing someone with colorectal cancer. Together, these factors, according to a binary 
logistic regression, created a significant model for predicting completion of colorectal 
cancer screening. However, only three of the variables were individually significant 
predictors: anxiety, FOBT/FIT vs scope, and being told to get screening. In this chapter, I 
provide further discussion of these findings, including interpretation, limitations, 
recommendations, and implications.  
Interpretation of the Findings 
  I conducted individual chi-square tests to examine the correlation between each 
survey item and the completion of colorectal cancer screening. The variables in the chi-
square tests that were significantly related to screening were embarrassment, fear of pain, 
fear of cancer, anxiety, being physically able to complete the test/preparation, awareness 
of screening at age 50, FOBT vs Scope, age of first screening at 50, being told to get 
screening, and knowing someone with colorectal cancer were significantly related to 
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screening. Only these variables were entered into the binary logistic regression. In the 
binary logistic regression model, the overall model was significant in that 64.5% of the 
variance of screening are due to predictors suggesting that all of these variables 
collectively have an impact on completion of colorectal cancer screening.  
The significant individual predictors in the model corresponded to anxiety, 
FOBT/FIT vs scope, and being told to get screening. Specifically, participants who 
indicated they were anxious were more likely to not have completed colorectal cancer 
screening when compared to participants who indicated they were not anxious. 
Participants who used the scope method were more likely to have completed colorectal 
cancer screening when compared to participants who used the FOBT method. 
Participants who were told to get screening were more likely to have completed 
colorectal cancer screening when compared to participants who were not told to get 
screened. There was no relationship between gender, race, education, age, transportation, 
understanding the preparation and completion of colorectal cancer screening. In the 
following subsections, I outline the relationship of these findings to the extant literature, 
as well as with relation to the theoretical framework chosen for the study.  
Relationship Between Findings and Extant Literature 
 An extensive review of the literature revealed no existing studies examining 
colorectal cancer screening variables among the mentally ill who obtain services from a 
CMH agency.  However, the existing literature revealed some findings that were 
primarily consistent with some of the factors that contributed to the significant model 
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found through the chi-square analysis. The following section outlines these factors and 
the related literature, as well as this study’s contributions to the literature.  
 The findings that fear of cancer and knowing someone with colorectal cancer 
contributed to predicting colorectal cancer screening were inconsistent with the literature. 
Meissner et al. (2012) assessed perceptions of primary care providers regarding 
individuals’ failure to receive colorectal cancer screening. One of the identified factors 
was that patients did not perceive themselves as susceptible to colorectal cancer 
(Meissner et al., 2012). Additionally, Almadi et al. (2015) determined that fear of 
unwanted outcomes contributed to individuals not seeking out colorectal cancer screening 
in Saudi Arabia, and Sohler et al. (2015) determined that knowledge did not contribute to 
colorectal cancer screening completion. Almadi et al.’s, Meissner et al.’s, and Sohler et 
al.’s studies consisted of individuals without mental illnesses, which may explain why the 
findings related to fear and knowledge of colorectal cancer did not align with the findings 
in this study. Fear of cancer is consistent with believing that one is susceptible to cancer, 
and knowing someone with cancer likely increases the reality of colorectal cancer and 
personal susceptibility; therefore, it is inconsistent that these individuals would not be 
more likely to seek out screening. The findings were, however, consistent with Ghobadi 
et al.’s (2016) findings among the general population in Iran that increasing patients’ 
perceptions of the benefits of colorectal cancer screening increased receipt of FOBT 
screening.  
 The finding that demographics did not influence colorectal cancer screening 
completion was also inconsistent with the limited previous literature. Almadi et al. (2015) 
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and Meissner et al. (2012) noted that primary care physicians identified not being able to 
pay for the treatment as having a relationship with decreased receipt of screening 
services. In contrast, socioeconomic status did not contribute to the model predicting 
colorectal screening completion in this study. This lack of awareness of key factors 
predicting screening completion may highlight the incongruity between primary care 
providers and those with mental illnesses, as well as the stigma associated with this 
population among healthcare providers (Howard et al., 2010). An alternate interpretation 
is that the sample was too homogenous with respect to socioeconomic status, with all 
individuals at or below the poverty line; therefore, the results cannot be generalized to a 
broader sample.  
 Another potential inconsistency with the literature was the increased likelihood of 
receiving screening using the scope method. As discussed in Chapter 2, the scope method 
requires patients to undergo significant preparation prior to receiving treatment 
(American Cancer Society, 2014). Some researchers proposed that the FOBT/FIT would 
therefore encourage more people to receive screening, since it requires less extensive 
preparation and increased patient self-efficacy (Bandi et al., 2011; Ghobadi et al., 2016; 
Glanz et al., 2015).  
Leard et al. (1997) emphasized the importance of knowing and adhering to 
patients’ preferences regarding colorectal cancer screening, and Ghobadi et al. (2016) 
noted that reducing perceived barriers to screening was a contributing predictive factor of 
colorectal cancer screening. Complicating this recommendation, the type of screening 
preferred was the FOBT/FIT; however, more people completed the colonoscopy. As a 
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result, this finding is significant for understanding colorectal cancer screening among 
those with mental illnesses. A potential interpretation of this finding is that since 
preparation for a scope test (adhering to a liquid diet the day before the test, drinking 
poor tasting fluids in order to clear the bowels which results in diarrhea, and needing 
someone to take the person to the test and home again) involve things that a patient may 
feel more comfortable personally completing than collecting and providing a stool 
sample, as required through the FOBT/FIT. This may relate to Ghobadi et al.’s finding 
that increasing patient self-efficacy contributed to receipt of colorectal cancer screening. 
In addition, in the general population, about 25% of colonoscopies fail due to poor 
preparation/clearing of the bowels (Hand, 2014). However, since fear of pain was also 
negatively related to colorectal cancer screening and a scope is more painful, researchers 
should further investigate these factors and how they interrelate with colorectal cancer 
screening completion.  
Several other findings of the present study were consistent with the extant 
literature. For example, Ferrante et al. (2013) determined that increased visits to primary 
care providers led to increased colorectal cancer screening among the general population. 
Similarly, within populations without mental illnesses, Almadi et al. (2015) determined 
that access to health care delivery systems contributed to colorectal cancer screening, and 
Sohler et al. (2015) noted discussions with a care provider increased colorectal cancer 
screening.  
Increased visits could also explain increased awareness of the need for screening 
at 50, adherence to screening at 50, and being told to get screening, factors that the 
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present study linked with colorectal cancer screening completion. In addition, Friedman 
et al. (2005) determined that among the mentally ill, medical providers recommendations 
were essential to cancer screening completion. The increased contact and comfort with a 
primary care provider could also explain a lessened feeling of embarrassment and shame, 
which this study and Almadi et al. found contributed to likelihood to complete colorectal 
cancer screening.  
One complication of the consistency of these findings with the literature is that 
problems between primary care providers and those with mental illnesses may exacerbate 
the lack of colorectal cancer screening services among the mentally ill. The previously 
published literature was conducted among general populations (e.g., Almadi et al., 2015; 
Meissner et al., 2012). In general, those with mental illnesses receive preventative 
services at a lower rate than the general population (Drus et al., 2002). Issues such as 
diagnostic/treatment overshadowing may contribute to primary care providers failing to 
recommend appropriate treatment (Howard et al., 2010). As such, the mentally ill may be 
less likely to receive the necessary information, assistance, and recommendations to 
receive colorectal cancer screening. This is particularly important since being told to get 
screening was an individual predictor of colorectal cancer screening completion.  
Relationship Between Findings and Theoretical Framework 
The research was conducted using a survey with a basis upon the HBM, as well as 
demographic information. Theorists of the HBM posit that the belief in a personal threat, 
together with the belief in the effectiveness of the proposed behavior, will predict the 
likelihood of patients’ behaviors (Rosenstock et al., 1988). Although the survey included 
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demographics and the role they play on completion of colorectal cancer screening, age, 
gender, race, education, and insurance status did not play a role in completion of 
colorectal cancer screening. Only factors related to perceived 
threats/barriers/susceptibility, cues to action, and self-efficacy, as present in the HBM, 
had a significant predictive relationship with colorectal cancer screening completion 
(Glanz et al., 2015). The results of the present study were partially consistent with these 
broad categories, as discussed below.  
Perceived threats, barriers, and susceptibility. This research attempted to 
identify whether or not the following barriers to colorectal cancer screening were 
relevant:  embarrassment, fear of pain, fear of cancer, anxiety, and method of screening. 
These variables were in line with the theoretical literature related to the HBM (e.g., 
Conner & Norman, 1996; Glanz et al., 2015; Rosenstock et al., 1988). In line with the 
HBM, collectively all of these variables were significant predictors of screening. Thus, 
the current findings suggested that the HBM’s explanation of perceived threats, barriers, 
and susceptibility is an adequate framework for understanding factors that predict 
colorectal cancer screening completion by individuals in this sample.  
Individually, only anxiety and completion of scope over FOBT/FIT were 
noteworthy. Individuals who indicated anxiety about screening were 8.33 times less 
likely to have it done. Therefore, the findings suggest anxiety about colorectal cancer 
screening is a significant perceived barrier that may impede colorectal cancer screening 
completion among those with mental illnesses.  
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Similarly, although participants reported that they preferred the FOBT/FIT, they 
were more likely to complete the scope test. The preference for FOBT/FIT is consistent 
with the HBM, inasmuch as providing a stool sample requires less preparation than the 
scope (American Cancer Society, 2014). However, the findings indicated that the actual 
preparation work is not a barrier to completion with the scope test. A potential 
interpretation of these findings is that the preparation for the scope test involves factors 
that individuals feel more comfortable controlling (e.g. diet changes and transportation), 
thereby increasing self-efficacy. On the other hand, the FOBT/FIT requires that the 
individual provide a stool sample, which may be uncomfortable and therefore increase 
the likelihood that the person will not complete the screening (Glanz et al., 2015).  
 Cues to action. Per the HBM, suspected cues to action evaluated were being told 
to get the screening and knowing someone who had colorectal cancer. Knowing someone 
who had colorectal cancer also increased testing completion at a minimally significant 
rate. Moreover, having a medical provider recommend screening increased success by 
59.84% for completion of colorectal screening; therefore, provider recommendation was 
an individual predictor of completion. Thus, the cues to action portion of the HBM were 
consistent with the results of the present study (Glanz et al., 2015).  
Self-efficacy. Suspected self-efficacy variables such as transportation, physical 
ability to complete screening, and being able to understand the procedure preparation 
were evaluated for this study. With regards to self-efficacy, only physical ability to 
complete the test contributed to the overall model that predicted screening completion in 
this population. Conversely, transportation and understanding of the preparation did not 
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play a role in completion of screening, inconsistent with the HBM (Glanz et al., 2015; 
Rosenstock et al., 1988) and previous research (Almadi et al., 2015; Sohler et al., 2015). 
This finding was inconsistent with Gholbadi et al.’s (2016) and Sohler et al.’s (2015) 
findings, which found a p value of less than .01 between self-efficacy and colorectal 
cancer screening within a sample of the general population. These findings suggested that 
self-efficacy plays less of a direct role than do cues to action and perceived threats and 
barriers to completion within those with mental illnesses. As previously mentioned, it 
may be fruitful to examine self-efficacy further with relation to the increased rate of 
scope completion when compared to FOBT/FIT in addition to whether or not the person 
was given a choice by the medical provider.  
Limitations of the Study 
There are several limitations to this study that were identified prior to the 
completion of its research. These limitations may be useful for guiding follow-up 
research. The limitations are as follows: 
Mental Illness Diagnosis 
Because many people do not know their exact diagnoses, I did not ask about 
specific mental illnesses in my survey instrument. For example, a patient might indicate 
that he or she has bipolar illness when, as the Diagnostic and Statistical Manual V 
indicates, it is currently referred to as bipolar depression, which is a different diagnosis. 
A patient might say that he or she has schizophrenia when the real diagnosis according to 
the Diagnostic and Statistical Manual V indicates that the person has schizoaffective 
disorder, which is similarly very different from schizophrenia. There was no way to 
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confirm correct diagnosis in this population group through a self-reporting anonymous 
survey; therefore, it was omitted. However, specific mental illnesses have different 
presentations that may have influenced the outcomes of the study, if considered.  
Mental Illness With Substance Abuse 
Co-occurring diagnosis confirmation of a substance abuse was also not considered 
in this study. One would have to identify each type of substance abuse (e.g., cocaine, 
heroin, alcohol, or combination) to determine the role that this plays in completion of 
colorectal cancer screening. The particular type of substance abuse, if identified, may 
have been a demographic variable that influenced the results.  
Sample and Generalizability 
The present study also had limitations with respect to the sample. Use of a 
convenience sampling procedure led to my inability to control variables and diversity 
with respect to demographic factors. The location of this study was also limited to the 
inner city of Detroit, as opposed to a more rural area, or to a more diverse sample of 
multiple locations. The agencies are in crime ridden areas; particularly one of the centers 
that has a high poverty/crime rate and is known on the streets as “car jack city.”   
In addition, the majority of the clients who participated in the study identified as 
black. This might be a limitation because people with darker skin have a higher rate of 
colorectal cancer, and medical providers often recommend colorectal cancer screening at 
age 45 for people with very dark skin. However, race was not a significant variable 
according to the present study.  
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 All of the participants were at poverty level, and most had Medicaid insurance; 
individuals with mental illnesses at a higher socioeconomic level could be more likely to 
complete colorectal cancer screening. It would be interesting to study only individuals 
with Medicare and their colorectal cancer screening rates. A larger, more diverse sample 
could increase the generalizability of the results.  
Transportation 
A specific limitation with respect to the study sample is the lack of influence of 
transportation on colorectal cancer screening completion. Transportation in the study was 
not a barrier to colorectal cancer screening. However, at the CMH studied, most of the 
Medicaid providers have free transportation services provided by the insurance company. 
It might be helpful to further study the use of transportation such as free services, 
Medicare vs. Medicaid, GI office-provided transportation for those without a loved one to 
transport and stay with him or her during a procedure, and other variables related to 
transportation in particular. In addition, at more rural locations, transportation might be 
less readily available, and therefore become an influential factor.  
Instrument 
 A final limitation was the measurement bias of the instrument. I did no 
psychometric testing of my instrument. Therefore, the instrument was a potential 
limitation of the study.  
Recommendations 
There was a lack of research investigating colorectal cancer screening variables 
among those with mental illnesses. This lacking focus represented a general malaise with 
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respect to the mentally ill regarding basic primary care (Howard et al., 2010). The 
primary recommendation for research and practice is to combat this apathy by sparking a 
focus on preventive care and services for those with mental illnesses, specifically with 
relation to colorectal cancer. Several additional recommendations for researchers and for 
clinical practice stem from this overarching recommendation.  
Recommendations for Future Researchers 
Additional research is needed regarding colorectal cancer screening among those 
with mental illnesses. This population is disproportionally affected by colorectal cancer, 
inasmuch as mortality is greater and diagnoses are lesser (Baillargeon et al., 2011; Kold 
et al., 2010). For example, researchers should determine whether and how fear of pain 
interrelates with the preference for the scope test demonstrated in the present study, and 
how this relationship affects colorectal cancer screening among those with mental illness. 
The present study determined that the HBM, especially cues to action and 
perceived barriers, threats, and susceptibility, was an adequate method of determining 
variables that influenced colorectal cancer screening completion among those with 
mental illnesses in this sample. Further researchers could use the HBM in similar studies 
to assess HBM variables which contribute to completion of other preventive healthcare 
by those with mental illnesses, including mammogram/pap tests, ophthalmology exams 
(in people with diabetes), optometry, dental care, routine physical exams, and bone 
density scans to name a few. Alternatively, researchers could also examine colorectal 
cancer screening through the theoretical frameworks of the modified HBM, in light of 
recent findings regarding the hierarchical nature and influence of the HBM (e.g., Jones et 
99 
 
al., 2015) or the theory of planned behavior, which may be more effective in explaining 
health care seeking behaviors than the HBM, as found by Gerend and Shepherd (2012).  
Some recommendations for future researchers result from the limitations of the 
present study. For example, CMH agencies are located in high socioeconomic cities as 
well as rural areas with low crime rates with various ethnic and racial distributions; 
therefore, future researchers should consider conducting a similar study in a different 
location. Researchers could consider including participants from several different sites in 
the United States. This additional research would help determine the generalizability of 
the HBM variables identified in the present study, as well as reduce the limitations with 
respect to the homogeneity of this study’s sample. This change could have implications 
for the results regarding demographics and transportation. Utilization of the Multi-theory 
Model (MTM) might also be used in helping to explain and predict health behaviors 
(Nahar, Sharma, Catalano, Ickes, Johnson, & Ford, 2016). 
Conducting the proposed research led to several recommended changes to the 
present study parameters. I recommend that a person be assigned to ask the questions to 
make sure that the participant understands what is being asked due to cognitive 
impairment common with mental illnesses as well as various educational levels of 
participants. This change could influence the outcomes of future studies. Future studies 
may also consider an alternative sampling method. People who came to the CMH for 
appointments became subjects upon completion of the voluntary questionnaire used in 
this study. Future researchers might want to assess which patients age 45 and older in 
order to find out who completed colorectal cancer screening, if it was recommended, and 
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why it was or was not completed. This might increase the sample size, allow for more 
accurate responses (someone explaining questions asked by phone or in person if there 
was any confusion), and increase knowledge related to variables that affect colorectal 
cancer screening completion. 
I also recommend that future researchers conduct studies of the Registered Nurse 
Assessment to determine if it is done on all patients yearly, if it includes 
recommendations for preventative screenings, how the information is conveyed to the 
patient/medical provider/treatment team, how it is monitored for completion, and if 
patient education is provided.  
Since recommendations from care providers were a significant predictor of 
screening completion, future researchers could consider this factor and variables that 
increased screening completion, such as computerization, clarity of recommendation, 
recommendations specific to race, family history, and age of person in relation to 
colorectal cancer screening. In addition, it may be relevant whether the RN educates the 
patient on various types of colorectal cancer screening, as well as assesses for anxiety, 
fear of testing, and ability to complete the preparation for the screening. Follow up on 
lapses in preventative screenings may also influence completion. The results of these 






The findings have implications at the clinical level. Results suggested that several 
variables related to the HBM influenced the completion of colorectal cancer screening 
among those with mental illnesses in a CMH agency: embarrassment, fear of pain, fear of 
cancer, anxiety, being physically able to complete the test/preparation, awareness of 
screening at age 50, FOBT/FIT vs scope, age of first screening at 50, being told to get 
screening, and knowing someone with colorectal cancer. Individual predictors, such as 
anxiety, FOBT/FIT vs scope, and being told to get screening, require specific attention 
from practitioners. Knowledge and awareness that these factors influenced decision 
making among this population would lead to some transformations in care, including the 
integration of the CMH agency into the colorectal cancer screening process.  
Firstly, an RN could conduct yearly Nursing Assessments on all CMH patients, 
which would include preventative health care with recommendations made to the primary 
care provider, patients, and case manager. These recommendations would also appear in 
the Person Centered Plan. All clients of the CMH develop a Person Centered Plan, which 
includes goals and ways to achieve them. Staff members usually help with a mandated 
“health and safety” section, which might include getting a physical exam yearly or seeing 
a dentist every six months. If an RN was part of the Person Centered Planning, then goals 
for preventative health care could be included in that goal. The goal might be for the 
person to ask his or her medical provider for colorectal cancer screening, rather than 
waiting for a recommendation. The RN could use this as a teaching opportunity to help 
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dispel fears of cancer/embarrassment/anxiety and educate the person on screening 
options.  
For colorectal cancer specifically, the RN could recommend the screening and 
assess need for screening earlier than 50 if there was a family history or symptoms 
present. Then, the RN can incorporate the need for this screening into the person’s 
physical health goal in the treatment plan. A case manager or other staff involved with 
implementation of the Person Centered Plan would monitor whether or not the person’s 
medical provider provided a prescription for a colonoscopy or stool sample testing, and 
assess the patient’s feelings about and understanding of the test and its preparation. For 
anxiety in particular, the RN could answer any questions and dispel any myths that the 
person might have about getting colorectal cancer screening.  
If the person did not follow through, a referral back to the RN could occur for 
assistance with identifying variables that are preventing the screening from taking place. 
For example, if a person is physically unable to complete the prep for a colonoscopy 
ordered by a medical provider, the RN could coordinate care, which might include 
facilitation of a prescription for a fecal stool sample instead. The RN could also provide 
instructions for providing the sample, which may include a speci-pan, a collection 
method that makes obtaining the sample easier for those who are physically unable to 
complete the test, which was a barrier to completing colorectal cancer screening in this 
study. One key consideration would be anxiety. The RN could pay careful attention to 
assessing the patient’s anxiety about the test, and answer any questions or concerns that 
the patient might have.  
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Another consideration could be the type of test. The present findings suggested a 
contradiction in the patients’ perceptions of colorectal cancer screening; while 
participants preferred the FOBT/FIT, they were more likely to complete the scope test. 
Considering a patient’s preference of test is essential to testing completion (Leard et al., 
1997); however, medical professionals need to put more consideration into the decision-
making process, including asking and receiving answers to specific questions about the 
preparation for both tests. For example, a medical care provider could ask:  
• “Would you feel comfortable adhering to a liquid only diet?”  
• “Would you be okay with taking this medicine?” and 
• “Could you provide a stool sample by taking some of your poop and smearing it 
on this slide?”  
They could also ask comparative questions, such as “Would you prefer to [do the prep for 
the scope test], or [the prep for the FOBT/FIT]?” When assessing this preference, 
medical staff should be specific and clear. Together, these questions could increase 
patients’ comfort with completing colorectal cancer screening (Glanz et al., 2015).  
Another important implication for clinical practice is the practice of increasing 
awareness of screenings and telling patients to receive screening. To increase care 
providers’ and patients’ awareness and therefore the likelihood that they would 
recommend or ask for colorectal cancer screening, a CMH could highlight a preventable 
illness every month, such as making March colorectal cancer screening month. The RNs 
could provide posters and literature on the importance of colorectal cancer screening in 
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the waiting room of the offices. Free literature for distribution could be obtained from 
local health departments and national health-related clearinghouses.  
Implications for Social Change 
A transformation of care so great is in line with an integrated system of care. 
Numerous federal, state, and local organizations recognize a lack of Integrated 
Healthcare between psychiatry and medical care. Newer models of care are being 
proposed that integrate patient-centered systems among multiple stakeholders (Pearson, 
2016). To meet the goals of increasing screening, as previously mentioned, CMH 
agencies need to work with patients, care providers, primary care providers, and other 
stakeholders.  
If the CMH were aware of client needs and someone was assigned to identify 
them and assist the person with completion of these recommendations, then disparities in 
death rates might change and preventative screenings might increase in this population 
group. The answer might be the development of a Health Advocate Team run by a 
Registered Nurse who develops a specific medical treatment plan that includes colorectal 
cancer screening recommendations and follow up. The medical goals would be 
discovered through a yearly Nursing Assessment. Specific preventative recommendations 
could be obtained by the RN through a template/computer program that includes 
preventative screenings, with drop down screens that appear depending upon the person’s 
age/gender/race. Primary care providers already utilize similar software to identify when 
to recommend various preventative healthcare screenings. At the end of the Nursing 
Assessment, recommendations could be integrated into the Person Centered Plan under 
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Medical Care. A copy of these recommendations could be electronically forwarded 
(mailed or faxed) to the primary care provider and other medical providers caring for this 
client. This way, a reminder is on board for the Primary Care Provider that colorectal 
screening is recommended. Part of the communication would indicate that he or she 
could contact the CMH RN for further assistance with the implementation of neglected 
recommendations. 
A Health Advocate Team run by the Registered Nurse could teach patients about 
FOBT/FIT and scope procedures, reduce anxiety, and reinforce the importance of 
screening. This team could also coordinate care with the medical provider and advocate 
for the patient should physical ability to complete screening via a scope method not be 
feasible, by assuring a prescription for the patient-preferred screening, and oversee 
completion of the screening. Emotional support would involve reducing embarrassment, 
anxiety, fear of pain, and fear of cancer. The Health Advocate Team would also teach the 
client ways self-navigate a complex health care system including how to keep track of 
appointments on a calendar, how to get transportation to medical appointments, become 
familiar/comfortable with medical providers. When able, the Health Advocate Team 
would discontinue services to the Case Management team for other non-health specific 
goal completion.  
 Such an integrated system would require extensive sharing of information, which 
could be achieved through information technology which might require funding for 
electronic medical records sharing. Because CMH agencies are rarely computer-linked to 
major medical centers, the ability to obtain medical information on CMH patients is often 
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very difficult. Even with mandated letters sent to primary care providers requesting 
information and, letting the provider know of CMH involvement in the person’s care, 
information sharing is often ignored. What recommendations a primary care provider has 
for patients also remains a mystery to CMH staff and sometimes the patient. Some CMHs 
are putting a medical provider in the clinic itself. However, there is limited research as to 
whether or not that would increase the likelihood of preventative care recommendation 
and completion. It might depend upon whether or not  an on-site medical provider has a 
computer system linked to the CMH itself in regard to information sharing with 
psychiatric providers.  It is also unclear whether or not the CMH staff would work with 
the clinic’s medical provider in helping clients obtain completion of colorectal or other 
preventative health care screenings.  The development of such an integrated healthcare 
delivery service should be studied to show evidence based success or lack thereof.   
 These changes in clinical practice could have significant influences for social 
change. Having CMH staff help clients add specific preventative health care goals to the 
Person Centered Plan would ensure completion and frequent monitoring of those goals, 
and thereby increase colorectal cancer screening completion and decrease disparities 
among those with mental illnesses. It could also lead to increased screening because of an 
increased understanding of the different perceptions surrounding FOBT and scope 
procedures. Focus on HBM variables, such as telling individuals to receive screening and 
reducing anxiety, may increase the completion of screening, and therefore lead to 
prevention (Conner & Norman, 1996). The variables identified in this research could be 
remedied through use of the Psychiatric Registered Nurse via an Annual Nursing 
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Assessment that includes an evaluation for variables that might deter colorectal and other 
cancer preventative screenings.  
In addition, social change could be effected since most CMH patients have 
Medicaid insurance, which is taxpayer funded. If colorectal cancer was prevented or 
caught early through screenings, it would be less expensive than having to pay for cancer 
care (chemotherapy, radiation therapy, surgery, hospitalizations, emergency room visits, 
and expensive medications). This can be expanded further into having CMHs ensuring 
that those with mental illnesses receive preventative health care. 
Conclusion 
When colorectal cancer is detected early, there is a high recovery rate (American 
Cancer Society, 2015); however, those with mental illnesses are at an increased rate of 
dying from lack of diagnoses from screening (Kold et al., 2010). Through this study, I 
identified variables that contribute to colorectal cancer completion among those with 
mental illnesses: anxiety, referrals to receive colorectal cancer screening, and FOBT/FIT 
vs scope. The implications for CMH agencies included a transformation of practice at the 
clinical level to consider mitigating anxiety, increasing referrals to receive screening 
tests, and focusing on patients’ perceptions and completion of FOBT/FIT and scope 
procedures. With these changes to practice, the results of the study have significance for 
social change for the mentally ill, who will receive better screening and therefore have 
better outcomes if diagnosed with colorectal cancer, as well as the general community 
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Appendix A: Colorectal Cancer Screening Preparation 
  
Key Instructions:  
Your bowel must be empty so that your doctor can clearly view your colon. Follow all of 
the instructions in this handout EXACTLY as they are written.  
Do NOT eat any solid food the ENTIRE day before your colonoscopy.  
 Buy your bowel preparation at least 5 days before your colonoscopy. Do NOT mix the 
solution until the day before your colonoscopy.  
A responsible family member or friend MUST come with you to your colonoscopy and 
REMAIN in the endoscopy area until you are discharged! You are NOT ALLOWED to 
drive, take a taxi or bus, or leave the Endoscopy Center ALONE. If you do not have a 
responsible driver (family member or friend) with you to take you home, your exam 
cannot be done and will be cancelled.  
Some of the medicines you take may need to be stopped or adjusted before your 
colonoscopy. You MUST call the doctor who ordered any of the following medicines at 
least 2 weeks before your colonoscopy. Blood thinners -- such such as Coumadin® 
(warfarin), Plavix® (clopidogrel), Ticlid® (ticlopidine hydrochloride), Agrylin® 
(anagrelide), Xarelto® (Rivaroxaban), Pradaxa® (Dabigatran), and Effient® (Prasugrel). 
Insulin or diabetes pills. please call the doctor that monitors your glucose levels. Your 
insulin dosage may need to be adjusted due to the diet restrictions required with this 
bowel preparation. (Please bring your diabetes medicines with you on the day of your 
procedure.) If you take aspirin, take it and ALL other medications prescribed by your 
doctor. On the day of your colonoscopy, take your medications with a sip of water.  
IMPORTANT - Please Read These Instructions at Least 2 Weeks Before Your 
Colonoscopy With General Anesthesia How to Prepare for Your Colonoscopy Using 
Prepopik Health Information For Patients and the Community Designated Driver on the 
Day of Your Exam Medications 
 If you do NOT follow the directions for when to start drinking the bowel preparation 
(see next page), your colonoscopy WILL be cancelled. Revised 1/2015 1 •Do NOT take 
medicines that stop diarrhea -- such as Imodium®, Kaopectate®, or Pepto Bismol®. •Do 
NOT take fiber supplements -- such as Metamucil®, Citrucel®, or Perdiem®. •Do NOT 
take products that contain iron -- such as multi-vitamins -- (the label lists what is in the 
products). •Do NOT take vitamin E. Buy the prescription bowel preparation at your local 
pharmacy or drugstore pharmacy. Do NOT eat high-fiber foods -- such as popcorn, 
beans, seeds (flax, sunflower, quinoa), multigrain bread, nuts, salad/vegetables, or fresh 
and dried fruit. Only drink clear liquids the ENTIRE DAY before your colonoscopy. Do 
NOT eat any solid foods. Drink at least 8 ounces of clear liquids every hour after waking 
up. The clear liquids you can drink include: •water, apple or white grape juice; broth; 
coffee or tea (without milk or creamer); clear carbonated beverages such as ginger ale or 
lemon-lime soda; Gatorade® or other sports drinks (not red); KoolAid® or other flavored 
drinks (not red). You may eat plain jello or other gelatins (not red) or popsicles (not red). 
Do NOT drink alcohol on the day before or the day of the procedure  
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Step 1: At 6 PM, the day before your procedure: • Fill the dosing cup provided with cold 
water up to the lower (5 ounce) line on the cup. • Pour in the contents of ONE (1) packet. 
• Stir for 2 to 3 minutes until dissolved. • Drink the entire contents. • Drink at least FIVE 
(5) additional 8 oz glasses of clear liquid, taken at your own pace, within the next 5 
hours.  
Step 2: At 11 PM, the evening before your procedure: • Fill the dosing cup provided with 
cold water up to the lower (5 ounce) line on the cup. • Pour in the contents of ONE (1) 
packet. • Stir for 2 to 3 minutes until dissolved. • Drink the entire contents. • Drink at 
least THREE (3) additional 8 oz glasses of clear liquid, before midnight. You may 
continue to drink clear liquids only until midnight. Do NOT eat or drink ANYTHING 
after midnight the night before your procedure or your procedure may be cancelled. This 
is for your safety and will reduce the risk of having food or liquid in your stomach move 
into your lungs (aspiration) during a procedure. If you take aspirin, take it and ALL other 
prescribed medicines with a sip of water on the day of your colonoscopy.  
If you are unable to keep your appointment or have any questions about the instructions, 
please call the facility where the procedure is being performed. Call between the hours of 
8:00 AM and 5:00 PM. If you are calling after 5:00 PM, please call Nurse on Call at 
216.442.0310. Contact Information Colonoscopy under general anesthesia using 
Prepopik Index # 15635  
Cleveland Clinic Main Campus Departments of Colorectal Surgery and Gastroenterology 
9500 Euclid Avenue Cleveland, OH 44195 216/444-7601  
A colonoscopy is an outpatient procedure in which the inside of the large intestine (colon 
and rectum) is examined. A colonoscopy is commonly used to evaluate gastrointestinal 
symptoms, such as rectal and intestinal bleeding, abdominal pain, or changes in bowel 
habits. Colonoscopies are also performed in individuals without symptoms to check for 
colorectal polyps or cancer. A screening colonoscopy is recommended for anyone 50 
years of age and older, and for anyone with parents, siblings or children with a history of 
colorectal cancer or polyps. To have a successful colonoscopy, your bowel must be 
empty so that your physician can clearly view the colon. To do this, it is very important 
to read and follow all of the instructions given to you at least 2 weeks BEFORE your 
exam. If your bowel is not empty, your colonoscopy will not be successful and may have 
to be repeated. If you feel nauseated or vomit while taking the bowel preparation, wait 30 
minutes before drinking more fluid and start with small sips of solution. Some activity 
(such as walking) or a few soda crackers may help decrease the nausea you are feeling. If 
the nausea persists, please contact nurse on call at 216.442.0310. You may experience 
skin irritation around the anus due to the passage of liquid stools. To prevent and treat 
skin irritation, you should: Apply Vaseline® or Desitin® ointment to the skin around the 
anus before drinking the bowel preparation medications. These products can be 
purchased at any drugstore. n Wipe the skin after each bowel movement with disposable 
wet wipes instead of toilet paper. These are found in the toilet paper area of the store. n 
Sit in a bathtub filled with warm water for 10 to 15 minutes after you finish passing a 
stool; after soaking, blot the skin dry with a soft cloth, apply Vaseline® or Desitin® 
ointment to the anal area, and place a cotton ball just outside your anus to absorb leaking 
fluid. During a colonoscopy, an experienced physician uses a colonoscope (a long, 
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flexible instrument about 1/2 inch in diameter) to view the lining of the colon. The 
colonoscope is inserted into the rectum and advanced through the large intestine. If 
necessary during a colonoscopy, small amounts of tissue can be removed for analysis (a 
biopsy) and polyps can be identified and entirely removed. In many cases, a colonoscopy 
allows accurate diagnosis and treatment of colorectal problems without the need for a 
major operation.  
You are asked to wear a hospital gown and an IV will be started. n You will meet with an 
anesthesiologist who will discuss the plan for your sedation with you. n You are given a 
pain reliever and a sedative intravenously (in your vein). You will feel relaxed and 
somewhat drowsy. n You will lie on your left side, with your knees drawn up towards 
your chest. n A small amount of air is used to expand the colon so the physician can see 
the colon walls. n You may feel mild cramping during the procedure. Cramping can be 
reduced by taking slow, deep breaths. n The colonoscope is slowly withdrawn while the 
lining of your bowel is carefully examined n The procedure lasts from 30 minutes to 1 
hour. n You will stay in a recovery room for observation until you are ready for 
discharge. n You may feel some cramping or a sensation of having gas, but this quickly 
passes. nIf sedation has been given,a responsible family member or friend must drive you 
home. n Avoid alcohol, driving, and operating machinery for 24 hours following the 
procedure. n Unless otherwise instructed, you may immediately return to your normal 
diet. We recommend you wait until the day after your procedure to resume normal 
activities. n If polyps were removed or a biopsy was taken, the physician performing your 
colonoscopy will tell you when it is safe to resume taking your blood thinners. n If a 
biopsy was taken or a polyp was removed, you may notice a little amount of rectal 
bleeding for 1 to 2 days after the procedure. If you have a large amount of rectal 
bleeding, high or persistent fevers, or severe abdominal pain within the next 2 weeks, 
please go to your local emergency room and call the physician who performed your 
exam.  
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Tests and Procedures 
Fecal occult blood test 
By Mayo Clinic Staff 
The fecal occult blood test (FOBT) is a lab test used to check stool samples for 
hidden (occult) blood. 
Occult blood in the stool may indicate colon cancer or polyps in the colon or 
rectum — though not all cancers or polyps bleed. 
Typically, occult blood is passed in such small amounts that it can be detected 
only through the chemicals used in a fecal occult blood test. 
If blood is detected through a fecal occult blood test, additional tests may be 
needed to determine the source of the bleeding. The fecal occult blood test can 
only detect the presence or absence of blood — it doesn't indicate potential 
sources of bleeding. 
Your doctor may recommend a fecal occult blood test to: 
Screen for colon cancer. If you're age 50 or older and at average risk of colon 
cancer, your doctor may recommend a fecal occult blood test every year to 
screen for colon cancer. In addition, however, you may need other screening 
tests that allow the doctor to examine the colon directly. 
Evaluate possible causes of unexplained anemia. Anemia is a condition in 
which there aren't enough healthy red blood cells to carry adequate oxygen to 
your tissues. Sometimes a fecal occult blood test is used to determine whether 
bleeding in your digestive tract — such as a bleeding ulcer — is contributing to 
anemia. 
Risks and limitations of the fecal occult blood test include: 
The test isn't always accurate. Your fecal occult blood test could show a 
negative test result when cancer is present (false-negative result) if your cancer 
or polyps don't bleed. 
Your test could show a positive result when you have no cancer (false-positive 
result) if you have bleeding from other sources, such as a stomach ulcer, 
hemorrhoid, or even blood swallowed from your mouth or your nose. 
Having a fecal occult blood test may lead to additional testing. When the 
fecal occult blood test result is positive but a follow-up colonoscopy is normal, 
your doctor may recommend further observation with another fecal occult blood 
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test, evaluation of your upper gastrointestinal tract, a repeat colonoscopy or a 
combination of these. 
Fecal occult blood tests can't detect all cancers. Some cancers detected by 
colonoscopy may not be detected by the fecal occult blood test. 
Various foods, dietary supplements and medications can affect the results of 
some fecal occult blood tests — either indicating that blood is present when it 
isn't (false-positive) or missing the presence of blood that's actually there (false-
negative). Your doctor may ask you to avoid certain foods or medicines. To 
ensure accurate test results, follow your doctor's instructions carefully. 
For about three days before the test, your doctor may ask you to avoid: 
Certain fruits and vegetables, including broccoli and turnips 
Red meat 
Horseradish 
Vitamin C supplements 
Pain relievers, such as aspirin and ibuprofen (Advil, Motrin IB, others) 
There are several types of fecal occult blood tests, each with a different approach 
to collecting and testing stool. They include: 
Guaiac fecal occult blood test (gFOBT). Your doctor typically gives you a test 
card with room for two or three samples or two or three test cards. 
You collect a stool sample from each of two or three bowel movements in a clean 
container, usually taken on consecutive days, and then use an applicator stick to 
apply a smear of stool to a specific area of a card. 
After the samples are dry, you return them to your doctor or a designated lab, by 
mail or in person. 
Flushable reagent pad or tissue. You can get this kit at a store without a 
prescription. 
You place the pad or tissue in the toilet bowl after a bowel movement, usually on 
three consecutive days. The pads change color when blood is present. 
You then report the changes to your doctor, usually on a mail-in form. 
Immunochemical fecal occult blood test (iFOBT, or FIT). The collection 
method for this test may depend on the manufacturer, but typically, you use a 
special spoon or other device to collect a sample of stool and store it in a 
collection container that comes with the test kit. 
The collection container is then returned to your doctor or a designated lab, by 
mail or in person. 
Immunochemical testing is newer than gFOBT. It doesn't require any dietary 
restrictions before sample collection, and testing can often be performed on a 
random stool sample. Immunochemical testing is also more sensitive than is 
gFOBT. 
For accurate results, follow the instructions and return the samples promptly. 
Your doctor will review the results of the fecal occult blood test and then share 
the results with you. 
Negative result. A fecal occult blood test is considered negative if no blood is 
detected in your stool samples. If you had the test to screen for colon cancer and 
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you're at average risk — you have no colon cancer risk factors other than age — 
your doctor may recommend waiting one year and then repeating the test. 
Positive result. A fecal occult blood test is considered positive if blood is 
detected in your stool samples. You may need additional testing — such as a 
colonoscopy — to locate the source of the bleeding. 
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Appendix C: Participant Consent Form 
Consent Form 
The purpose of this research project is to determine what variables contribute to 
completion of colorectal cancer screening. 
You are invited to participate in this research project because you are age 50-75, do not 
have a legal guardian, and have health insurance. You also have a diagnosis of a mental 
illness and get services from a CMH agency. 
Your participation in this research study is voluntary. You may choose not to participate. 
If you decide to participate in this research survey, you may withdraw at any time. If you 
decide not to participate in this study or if you withdraw from participating at any time, 
you will not be penalized. You can still turn the uncompleted form in to the locked box 
on this table. 
The procedure involves filling out a short questionnaire that will take approximately 5 
minutes. Your responses will be confidential and we do not collect identifying 
information such as your name or insurance information. 
This form will not be linked to you in any way. The results of this study may be 
published and will be turned in to Walden University as part of a PhD Dissertation 
project that Kelly Gardiner is part of. This agency is not otherwise involved in this 
research. 
This will not affect your treatment in any way from Kelly or anyone else because she will 
not know whether or not you completed this survey. 
I understand that my name will not be used and that the results will be studied for 
research about colorectal cancer screening. 
____________ ok (mark with an X) 
If you have questions or concerns about this form, please contact 







Appendix D: Poster in Lobby Explaining CRC Screening 
 
A colonoscopy is a procedure where a medical provider puts a tube, with a camera on it, 
into your intestine. This is used to check for cancer or conditions that can turn into 
cancer. Prior to the test you have to take medicine that causes diarrhea and only drink 
clear liquids for an entire day. This will make sure that your intestines are clean for the 
camera to view them. You have to have someone drive you to the procedure, stay with 







 A Fecal Occult Blood Test is when your medical provider gives you a kit and you 





Appendix E: Poster in Lobby Asking for Participants 
Are you age 50-75? 
Are you a patient here? 
Are you your own guardian? 
Please help with valuable research!!! 
 
 
Please fill out the short survey on the clipboard located on this table. Put it in the locked 





Appendix F: Survey 
Colorectal Cancer Screening Questionnaire 
Age __________     Year you were born __________ 
Race __________ 
Male: _____   Female: _____  Transgender: _____ 
How far did you go in school? 
Middle school __________  High School __________ GED __________ 
Beyond high school _________ 
Insurance: Medicaid _____  Medicare ______  Both ______ Not sure _______ 
1)  Do you have someone who would take you to a medical procedure and stay with you 
for a few hours while it took place? 
 Yes ____ 
 No ____ 
2) Did anyone ever ask you to get a colonoscopy? 
 Yes ____ 
 No ____ 
3)  Do you think you are physically able to complete the colonoscopy preparation? 
 Yes ____ 
 No ____ 
4) Did anyone ever ask you to give a fecal (poop) sample on a glass slide? 
 Yes ____ 
 No ____ 
     If YES, did you give the sample to the medical provider?  
            Yes____ 
             No____ 
     If YES, how many years ago was it? 
            ____________________________ 
5)  Did you know that it is recommended that you have a colorectal cancer screening after 
age 50? 
 Yes ____ 
 No ____  
     If you knew that you should get this test done, who told you about it? 
 Family ____  
 Friend ____ 
 Medical person ____ 
 Newspaper/TV ____ 
 Other ____ 
6) Please check reasons to get a colorectal cancer screening. 
 Prevent cancer ____ 
 Check for cancer ____ 
 Remove cancer ____ 
7) Would you get embarrassed getting a colonoscopy? 
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 Yes ____ 
 No ____ 
8) Would you be ok if you had to drink only liquids for one day and these liquids would 
cause diarrhea? 
 Yes ____ 
 No ____ 
9) If you knew you needed to get a colorectal cancer screening and did not get it done, 
why? (Can check multiple boxes) 
 No time____ 
 Forgot ____ 
 No one told me to get it ____ 
 Not sure ____ 
 Didn’t understand the preparation before the test ____ 
 Didn’t have anyone to take me and stay with me during the procedure ____ 
 Wasn’t told to get it done ____ 
Fear of pain ____ 
Anxiety ____ 
Fear of being diagnosed with cancer____ 
Cancer doesn’t run in my family ____ 
10)  Did you notice any symptoms of potentially having colorectal cancer? 
 Yes ____ 
 No ____ 
 
11)  Have you actually completed a colonoscopy procedure? 
 Yes ____ 
 No ____ 
        How many years ago?_______________________________ 
YOU ARE FINISHED UNLESS YOU HAVE OR HAVE HAD COLO-RECTAL 
CANCER IN THE PAST. Thank you. 
        
12) Did you have or do you currently have colorectal cancer? 
      Yes________________ 
      No________________ 
      IF YES, What age were you diagnosed?_______________________ 
      Did you have a colonoscopy or gave a poop sample in a kit to your medical provider 
prior to diagnosis, that was normal? 
      Yes__________________ 
       No__________________ 
      How old were you then?_________________________ 
      How did you get diagnosed, if you have colorectal cancer? 
      FOBT_____________ 
      Colonoscopy______________________ 
      Did you have symptoms that made you get screened? 
      Yes__________________ 
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      No__________________ 
 
 
 
 
 
 
 
 
 
